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 Zusammenfassung 
 
Zusammenfassung 
 
Erythrozyten sichern die Sauerstoffversorgung aller Körperzellen und sorgen 
gleichzeitig für den Abtransport von CO2. Der intensive Kontakt mit Sauerstoff führt 
zu Schädigungen, die die ständige Neubildung von Erythrozyten unerlässlich 
machen. Die lebenslange Produktion roter Blutzellen setzt das Vorhandensein von 
hämatopoetischen Stammzellen voraus, die nicht nur die Fähigkeit besitzen 
müssen, sich während der gesamten Lebensspanne eines Individuums zu teilen 
(Proliferation), sondern auch jene, durch Reifung (Differenzierung) alle Typen von 
Blutzellen hervorzubringen. Die molekularbiologischen Prozesse die während der 
Entwicklung von der hämatopoetischen Stammzelle zum reifen Erythrozyten 
ablaufen sind bis heute nicht vollständig bekannt. Bei der Erforschung dieser 
Vorgänge kommt der Kultivierung erythroider Vorläuferzellen (Progenitoren) eine 
entscheidende Rolle zu. In vitro Kulturen ermöglichen die Untersuchung spezifischer 
Faktoren und deren Einfluss auf erythroide Progenitoren unter kontrollierten 
Bedingungen. So konnte beispielsweise gezeigt werden, dass Dihydrotestosteron 
die Zellteilung weiblicher Erythroblasten anregt, ein Effekt, der in männlichen Zellen 
nicht beobachtet werden konnte. Das in dieser Arbeit verwendete erythroide 
Zellkultursystem für humane Zellen ermöglicht die Langzeit-Kultivierung sowie 
Differenzierung von aus Nabelschnur- und peripherem Blut gewonnenen eryhtroiden 
Progenitoren. Dieses Zellkultursystem sieht die Verwendung von humanem Serum 
während der Differenzierung vor. Da Serum eine Vielzahl an Stoffen enthält, die 
unterschiedlich auf die Zellen wirken, ist sein Einsatz problematisch. Aus diesem 
Grund wurde in dieser Diplomarbeit die Wirkung von im Serum enthaltenen Faktoren 
auf differenzierende erythroide Zellen genauer untersucht, mit dem Ergebnis, dass 
ein für die Differenzierung wesentlicher Faktor eine molekulare Masse zwischen 3 
und 6kD aufweist. Neben diesem Faktor, den es noch zu identifizieren gilt, stellt im 
Menschen, im Gegensatz zur Maus, das Schilddrüsenhormon T3 einen weiteren 
wesentlichen Differenzierungsfaktor dar. Das Hauptaugenmerk dieser Diplomarbeit 
lag in der Untersuchung zweier von T3 beeinflusster Gene, nämlich denen für das 
Oberflächenprotein Spectrin ß und Caspase 7, einem der Hauptregulatoren des 
programmierten Zelltodes. Es konnte eine Regulierung dieser Gene durch T3 auf 
Proteinebene nachgewiesen werden. Weiters wurden lentivirale Partikel produziert 
mit deren Hilfe eine verminderte Expression dieser Gene erreicht werden sollte. 
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 Zusammenfassung 
 
Abstract 
 
Erythrocytes guarantee the oxygensupply of all body cells and remove 
simultaneously CO2 from tissues. These vital processes lead to damages of the 
red blood cells, due to permanent contact with high oxygen levels. This makes the 
constant replenishment of the erythrocyte pool an essential challenge. The life-long 
production of red blood cells requires the existence of haematopoietic stem cells 
not only capable to self-renew throughout the entire life-span of an individual 
(proliferation), but also to develop into the whole spectrum of mature blood cells 
(differentiation). Until now the molecular biological processes during development 
from the haematopoietic stem cell to the mature erythrocyte are still not fully 
elucidated. Cultivation of erythroid progenitor cells plays a critical role in the 
systematic study of these processes. In vitro cultures allow analysis of specific 
factors and their influence on erythroid progenitors under defined conditions. For 
example, we observed a proliferation-promoting effect of dihydro-testosterone on 
female erythroblasts, which could not be observed in erythroid cells derived from 
male donors. The erythroid cell culture system used for human cells, derived either 
from umbilical cord blood or peripheral blood, allowed both long-time proliferation 
and differentiation of erythroid progenitors. This cell culture system avoided the 
use of human serum during differentiation. Due to the fact that serum contains 
multiple components affecting erythroid cells in diverse ways, its use is suboptimal. 
In this diploma thesis the effect of serum constituents onto differentiating erythroid 
cells was analysed, with the result that one novel, so far undescribed essential 
factor for successful erythroid differentiation has an apparent molecular weight 
between 3 and 6kD. Beside this factor, which has to be identified, also free thyroid 
hormone (T3) represents an important maturation-promoting factor. The main 
focus of this diploma thesis laid on the analysis of two genes influenced by T3, the 
membrane-protein spectrin ß and caspase 7, one of the key regulators of 
apoptosis. Western blot analysis showed a regulation of these genes by T3 at the 
protein level. Additionally, lentiviral particles were produced to knock down the 
expression of these genes in human erythroid cells. 
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1 Introduction 
 
1.1 Haematopoiesis 
 
Haematopoiesis is the process through which all mature blood cells arise. The cells 
giving blood its red colour are the haemoglobin-containing erythrocytes. They are 
responsible for oxygen transport through the body. This is a stressful process 
causing oxidative damage to the erythrocytes. Because of that their lifespan is 
limited to about 90-120 days. Thus it is essential for the organism to produce new 
red blood cells efficiently throughout the whole life of an individual (about 30g a day). 
For this challenge cells are needed, which are competent in both critical processes: 
proliferation and differentiation. This is achieved by haematopoietic stem cells 
(HSCs). They are able to self-renew and can undergo differentiation into all blood 
lineages (Weissman 2000). Both processes, proliferation and differentiation, have to 
be controlled very precisely to avoid anaemia or erythrocytosis. Haematopoiesis is 
managed by strictly coordinated patterns of gene expression. Growth factors and 
hormones play an important role in this context. They assist HSCs in choosing one 
of their diverse fates, which are not only self-renewal and commitment to 
differentiation but also commitment to senescence or cell death. The ability to self-
renew guarantees a constant number of HSCs and simultaneously production of the 
corresponding mature cells. 
During embryogenesis, the original HSC pool has to be established. In this process, 
multiple anatomic sites are involved (Figure 1.1). One of these sites, which is the 
first source of definitive HSCs, is the yolk sac (Li, Johnson et al. 2003; McGrath and 
Palis 2005). Cells from the yolk sac are able to reconstitute multi-lineage, long-term 
haematopoiesis in genetically HSC-deficient newborn mice (Yoder 2004) but fail in 
adult bone marrow repopulation (Lensch and Daley 2004). Another important site in 
the context of HSC generation is the aorta-gonad mesoneprhros region or AGM 
(Muller, Medvinsky et al. 1994; Medvinsky and Dzierzak 1996; Godin and Cumano 
2002). The AGM is an anatomic region consisting of the dorsal aorta, its surrounding 
mesenchyme and the urogenital ridges. Beside the AGM, also the umbilical and 
vitelline arteries are additional sites for HSC development (de Bruijn, Speck et al. 
2000), as well as the placenta (Alvarez-Silva, Belo-Diabangouaya et al. 2003; 
Mikkola, Gekas et al. 2005; Rhodes, Gekas et al. 2008). The main organ for HSC 
expansion and red blood cell generation during late embryonic development is the 
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foetal liver. During that period the foetal liver grows rapidly and has to be supplied 
with HSCs from other sites. 
After the expansion of HSCs in the foetal liver, they finally become quiescent in their 
ultimate niche, the bone marrow. During postnatal life, it is important that a steady 
state is established, in which the balance between self-renewal and differentiation of 
HSCs is regulated according to the needs of the organism. 
 
 
 
 
 
 
 
 
Figure taken from Mikkola and Orkin 2006 
 
 
Figure 1.1: Sites of haematopoietic development during embryogenesis 
Different anatomic sites are involved in the establishment of foetal blood. Depending on the stage of 
development, these sites alter their activity. The first HSCs could be observed in the yolk sac, during 
late embryogenesis the foetal liver is the most important haematopoietic organ.  
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1.1.1 HSCs & their niche 
 
To maintain their self-renewal property, HSCs need a special subsidiary 
microenvironment, the so called stem cell niche. The niche of HSCs in adult 
mammals is the bone marrow. 
Bone marrow is highly organized, forming a three-dimensional microenvironment 
with different cell types and an extra cellular matrix, consisting mainly of fibronectin 
and collagen. Many HSCs reside near the endosteum (Petit, Szyper-Kravitz et al. 
2002). This is a fine stratum of vascular connective tissue at the interface between 
bone and bone marrow, where different cell types can be found: Bone-synthesizing 
osteoblasts and bone-resorbing osteoclasts are typical for this region as well as 
vascular cells. It is supposed that interaction of these cells regulates both, bone 
forming and haematopoiesis. As mentioned before, special factors are required for 
HSC maintenance. Some of them are already identified, like angiopoietin (Arai, 
Hirao et al. 2004), osteopontin (Nilsson, Johnston et al. 2005), stem cell factor (SCF) 
and thrombopoietin (Qian, Buza-Vidas et al. 2007). 
Angiopoietin is a growth factor predominantly promoting the formation of blood 
vessels. It has been shown that a combined loss of the angiopoietin-receptors Tie1 
and Tie2 causes defects in postnatal haematopoiesis (Puri and Bernstein 2003). 
Osteopontin is synthesized by different cell types, like for example osteoblasts. This 
matrix glycoprotein negatively regulates the HSC pool size (Stier, Ko et al. 2005). 
SCF is an important proliferation factor of HSCs as well as more mature 
haematopoietic progenitors. The receptor of SCF, c-Kit, is already expressed on the 
surface of early haematopoietic progenitors and also interacts indirectly with the 
cytoplasmic domain of the Epo-Receptor (Broudy, Lin et al. 1998). 
Thrombopoietin is, among others, synthesized by osteoblasts and stromal cells of 
the bone marrow (Guerriero, Worford et al. 1997; Yoshihara, Arai et al. 2007). Mice 
deficient in thrombopoietin or its receptor c-Mpl have a severe reduction in the 
amount of HSCs (Kimura, Roberts et al. 1998; Kirito, Fox et al. 2003). 
As osteoblasts produce both positive (angiopoietin) and negative (osteopontin) 
regulators for the maintenance of HSCs, they seem to be essential for 
haematopoiesis. 
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1.2 Erythropoiesis 
 
1.2.1 From HSCs to erythrocytes 
 
In adult individuals the immediate place where erythroblasts turn into erythrocytes is 
the erythroblastic island (Allen and Dexter 1982). These structures are placed 
throughout the bone-marrow and are made up of a central macrophage and varying 
numbers of erythroblasts in different developmental stages. During their maturation 
erythroblasts shrink in size and turn into normoblasts. At this stage, the nucleus 
becomes smaller and moves to the periphery of the cell. Finally, the nucleus is 
coated with a fine cell plasma layer and extruded. After the extrusion of the nucleus, 
the cell is released into the blood stream, where it develops into a reticulocyte and 
finally, assuming its typical biconcave shape, matures into an erythrocyte. 
The erythroblastic island supports the maturation of erythroblasts. The central 
macrophage secretes several cytokines needed for differentiation, like for example 
insulin-like growth factor, IGF-1 (Kurtz, Hartl et al. 1985). Furthermore, erythropoietin 
mRNA was observed in macrophages (Rich, Vogt et al. 1988). Another role of the 
central macrophage is phagocytosis of the extruded erythroid nuclei (Seki and 
Shirasawa 1965). Adhesion of erythroblasts to the macrophage and vice versa is 
directed by adhesion molecules, like erythroblast macrophage protein (Emp) found 
on the surface of macrophages as well as on the surface of erythroblasts (Hanspal 
and Hanspal 1994). The attachment is accomplished by homophilic binding. It has 
been shown that this interaction is simultaneously a protection against apoptosis and 
a support for differentiation (Hanspal, Smockova et al. 1998). 
Development of HSCs into mature erythrocytes is a complex process which 
proceeds via several intermediate stages (Figure 1.2). These intermediates cannot 
be discriminated properly by morphology alone but by flow cytometry (see section 
“Cell surface markers for haematopoietic progenitors”). 
Long-term HSCs (LT-HSCs) have the ability to self-renew during the whole life-time 
of an organism. They give rise to short-term HSCs (ST-HSCs). Following this 
transition, the capacity for self-renewal can be observed only for 8 weeks. ST-HSCs 
differentiate to multi-potent progenitors (MPPs) of limited proliferation capacity but 
still constantly supplying the organism with cells from the whole spectrum of 
hematopoietic lineages (Morrison, Wandycz et al. 1997). After the identification of 
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common myeloid progenitors (CMPs) (Akashi, Traver et al. 2000) and common 
lymphoid progenitors (CLPs) (Kondo, Weissman et al. 1997) it was postulated that 
the first lineage restriction takes place when MPPs commit either to the lymphoid or 
the myeloid lineage. Why a single MPP commits to one of these two lineages still 
remains unclear. CMPs, however, develop into an erythroid and a myeloid branch, 
represented by the megakaryocyte/erythroid progenitor (MEP) and the 
granulocyte/macrophage progenitor (GMP). CLPs differentiate either into T- and B-
lymphocytes or into Natural Killer Cells (NKC). 
The earliest distinct progenitor within the erythroid lineage is the burst forming unit-
erythroid, (BFU-E). BFU-Es are able to generate a burst of about 500 red cells in a 
time of 6-10 days (Heath, Axelrad et al. 1976; Iscove et al. 1974). BFU-Es 
differentiate into colony forming units-erythroid (CFU-Es). A CFU-E is able to form a 
colony with up to 32 cells within 2-3 days (Stephenson, Axelrad et al. 1971). After 
transition from CFU-Es to the stage of erythroblasts, development ends with mature 
red blood cells.  
 
 
 
1.3 Erythroid cells in culture 
 
To study the complex processes during red cell development, a tissue culture 
system is required which allows both biochemical and molecular biological analyses 
(Figure 3). This system has to meet several requirements. First, large numbers of 
homogenous progenitors have to be generated. Several kinds of primary cell model 
systems were already reported in the 1980s (Udupa, Crabtree et al. 1986). The 
problems of these systems were either insufficient cell production or heterogeneity of 
the cells obtained. Second, the cultured cells should behave similarly as those in 
vivo. Therefore, experiments using erythroleukaemic cell lines resulted in some 
insights but did not reflect the in vivo situation (Kabat, Sherton et al. 1975; Dean, 
Erard et al. 1981). Third, it should be possible to control the amount of growth 
factors in the medium precisely. 
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Figure 1.2: Simplified scheme of haematopoiesis 
The pluripotent HSC is able to self renew throughout the whole lifespan of an individual. The 
proliferation rate is coordinated with the needs of the body and therefore tightly regulated. Beside 
proliferation, HSCs can also undergo differentiation into more and more committed progenitors, which 
ends with the creation of all kinds of mature blood cells. 
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Some earlier primary cell culture systems for erythroid progenitors originated from 
chicken (bone marrow), mouse (foetal liver) and human (umbilical cord blood) 
worked with serum plus a cocktail of factors (Epo, dexamethasone [Dex], SCF) 
involved in stress erythropoiesis (Bauer, Tronche et al. 1999; von Lindern, Zauner et 
al. 1999; Wessely, Bauer et al. 1999). In order to control the amount of the added 
proliferation factors precisely, the use of serum was suboptimal, because it contains 
a variety of different factors like hormones and proteins at unknown concentrations. 
For this reason, serum-free erythroid culture systems were established (Lebkowski, 
Schain et al. 1995; Neildez-Nguyen, Wajcman et al. 2002). 
Sources for CD34+ erythroid progenitors also used here are the murine foetal liver 
and, for human cells, peripheral (Fibach and Prus 2005) as well as umbilical cord 
blood (Sakatoku and Inoue 1997; Panzenbock, Bartunek et al. 1998; Leberbauer, 
Boulme et al. 2005). Although erythropoiesis takes place primarily in the bone 
marrow, a small number of HSCs is also present in the peripheral blood of adult 
humans (Goodman and Hodgson 1962). Umbilical cord blood, however, is more 
frequently used as source of human erythroid progenitors (Broxmeyer, Srour et al. 
2006). 
The pattern of cultured erythroid progenitors during expansion resembles the in vivo 
process of stress erythropoiesis (von Lindern, Deiner et al. 2001), which takes place 
after heavy blood loss and in case of anaemia or hypoxia. Cultured erythroid 
progenitors are conditioned to the factors active during stress erythropoiesis and 
undergo apoptosis if any single of these factors is omitted from the medium (Dozing, 
Kolbus et al. 2005). 
 
1.3.1 Growth factors for in vitro proliferation 
 
For in vitro proliferation of erythroid progenitor cells a specific factor mix, composed 
of Epo, Dex and Igf1 is needed. 
The glycoprotein hormone Epo is one of the key regulators in erythropoiesis. In 
mice, knock out of Epo or its receptor leads to death in utero at embryonic day 13 
(Wu, Liu et al. 1995). Although the amounts of BFU-Es and CFU-Es are comparable 
with the wild type situation, there is a loss of mature erythrocytes. Because of this 
Epo, respectively its receptor must be essential during or directly after the CFU-E 
stage. The Epo receptor (EpoR) belongs to the cytokine receptor superfamily and is 
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a homodimeric type I membrane protein. Its extra cellular domain is able to bind Epo 
and is therefore called Epo-binding domain. During normal conditions, only 
approximately 6% of EpoRs are occupied (Syed, Reid et al. 1998). This overspill of 
EpoRs is necessary for instance in case of severe blood loss, when Epo levels can 
increase up to 1000fold. EpoR+/- mice show normal haematocrit but have problems 
to deal with stress erythropoiesis (Jegalian, Acurio et al. 2002). Furthermore, it was 
observed, that Epo also protects early erythroid progenitors against apoptosis 
(Koury and Bondurant 1990). The binding of Epo causes activation of the 
transcription factor signal transducer and activator of transcription 5 (STAT5) which 
results in the translation of the anti-apoptotic protein Bcl-XL. The protective effect of 
Epo seems to be needed not only during proliferation but also during differentiation. 
It has been shown that Epo cooperates with SCF during proliferation which results in 
an increased number of cell divisions until terminal maturation (Wessely, Bauer et al. 
1999). This is true in the case of primitive as well as more mature haematopoietic 
progenitor cells. During differentiation, SCF has a retarding effect (Muta, Krantz et 
al. 1995). Due to alternative splicing, SCF occurs in two isoforms. One consists of 
165 amino acids and is water soluble, the other one consists of 220 amino acids and 
is membrane-bound. SCF is encoded in the Steel locus (Zsebo, Williams et al. 1990) 
localised on chromosome 12 in human and on chromosome 7 in mice (Anderson, 
Williams et al. 1991). Mutations in the locus for SCF or its receptor, c-Kit, result in 
similar phenotypes characterized by severe anaemia (Broxmeyer, Maze et al. 1991; 
Williams, de Vries et al. 1992). c-Kit is expressed on 1-5% of the cells in the bone 
marrow (Papayannopoulou, Brice et al. 1991). Besides haematopoietic progenitors, 
also platelets (Grabarek, Groopman et al. 1994), magakaryocytes (Briddell, Bruno et 
al. 1991) and some non-haematopoietic cells express c-Kit. Mutations in the gene 
encoding c-Kit are associated with some kinds of cancer and modifications in the 
c-kit expression pattern. For example, in case of acute myeloid leukaemia (AML) 
blast cells express c-kit (Ikeda, Kanakura et al. 1991). Epo has the ability to 
stimulate c-kit, which could be an indication for a relationship between these two 
proteins in haematopoietic target cells (Briddell, Bruno et al. 1991). Interactions 
between Epo/EpoR and SCF/c-Kit are required for long-term proliferation of 
erythroblasts in vitro (Wessely, Bauer et al. 1999). Furthermore, SCF also 
cooperates with the synthetic glucocorticoid hormone Dex. This supports the 
proliferation of chicken bone marrow cells and causes proliferation to last for about 
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27 days in vitro. In cooperation with Epo and SCF, Dex induces mouse erythroid 
progenitors to undergo 15-22 cell divisions, corresponding to a 105-106-fold 
amplification of erythroid cells (von Lindern, Zauner et al. 1999; Dolznig, Habermann 
et al. 2002). Furthermore von Lindern showed the delaying effect of Dex in terminal 
differentiation into erythrocytes. 
Another frequently used growth factor for proliferation is Igf1. It is a protein hormone 
whose molecular structure is similar to insulin. At physiological concentrations, Igf1 
stimulates erythroid colony formation of murine foetal liver and adult bone marrow 
cells (Kurtz, Jelkmann et al. 1982) and inhibits apoptosis of in vitro cultures 
(Rodriguez-Tarduchy, Collins et al. 1992; Muta, Krantz et al. 1994). 
A rather unexpected support for proliferation of human erythroid progenitors comes 
from the androgen dihydro-testosterone. This effect is observed exclusively in cells 
derived from umbilical cord blood of female donors. Cells originating from male 
donors show no response to the hormone (Leberbauer, Boulme et al. 2005). That 
sex hormones might play a role in haematopoiesis was already supposed after the 
observation that dysfunctions in the level of sex steroids correlate with 
haematological abnormalities (Besa and Bullock 1981; Mooradian, Morley et al. 
1987; Orwoll and Orwoll 1987; Claustres and Sultan 1988) but never rigorously 
tested. 
For outgrowth of erythroid progenitors derived from peripheral blood addition of 
interleukin-6 (IL-6) and Flt3-ligand (Fibromyalgia syndrome like tyrosine kinase 3) is 
necessary for the first 6 days in culture. 
Interleukin 6 is secreted by T cells, macrophages and osteoblasts and acts as both 
pro- and anti-inflammatory cytokine to trigger immune responses. It has been shown 
that the IL-6 receptor in synergy with Epo or Flt3 plays a role in HSC expansion 
(Ueda, Yoshida et al. 2001). 
Flt3 has anti-apoptotic effects and promotes rapid cell divisions in erythrocyte 
progenitors (Poloni, Douay et al. 1997; Murray, Young et al. 1999).  
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Figure 1.3: Human & murine erythroid cell culture systems 
A) Human blood is collected and erythrocytes removed by lyses. The resulting cells represent a 
heterogeneous population of all mononuclear cells plus thrombocytes. After about 8 days (CB) 
and 10 days (PB) in culture with the appropriate medium enriched with proliferation growth 
factors, a homogenous erythroblast culture is established. Erythroblasts obtained from peripheral 
blood additionally need supplementation with Flt3 and IL-6 for the first 6 days in culture. 
B) Murine foetal livers are harvested between E11.5 and E13.5. Comparable to the human system, 
the initial preparation contains different cell types. The outgrowth of homogenous erythroblasts 
takes about 4 days. 
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1.3.2 Growth factors for in vitro differentiation 
 
Erythroblasts have a restricted ability to proliferate for a short time period. For 
mouse in vitro cultures, the factor mix for proliferation (Epolow, Dex, Igf1, SCF) has to 
be changed to the one inducing differentiation (Epohigh, insulin, ZK, human 
transferrin) before erythroblasts lose their self-renewal capacity (Dolznig, Bartunek 
et al. 1995; Dolznig, Boulme et al. 2001). If this is not done, erythroblasts will 
undergo apoptosis. After addition of differentiation factors, erythroblasts initiate 
terminal maturation into erythrocytes in a synchronous and effective manner. During 
differentiation cell size decreases, haemoglobin is accumulated and the nucleus gets 
condensed and finally extruded. 
In the presence of differentiation factors, murine erythroid progenitors complete 
differentiation within 3 days and become morphologically similar to erythrocytes in 
vivo. They are fully haemoglobinized and approximately 70% of the cells extrude 
their nucleus. Differentiation of human erythroid progenitors, however, takes about 
twice as long. The generation of enucleated cells takes six days and even then the 
majority of cells still contain their nucleus. 
Epo is not only needed for proliferation, it plays also a key role in differentiation: Epo 
alone has the power to induce differentiation of erythroid progenitors (Muta, Krantz 
et al. 1994; Muta, Krantz et al. 1995). The most effective dose of erythropoietin 
during differentiation is about five times higher than during proliferation. The 
interaction partner of c-Kit during differentiation is no longer SCF, it is replaced by 
Insulin (Ins). 
As mentioned before, glucocorticoids like Dex retain erythroid cells in an immature 
state. To avoid this effect the glucocorticoid-receptor antagonist ZK112993 (ZK) is 
added to the differentiation mix. 
Another differentiation factor for human and avian erythroid cells but not for murine 
ones, is the thyroid hormone 3,5,3’-triiodothyronine (T3). Apparently, lack of thyroid 
hormone can be associated with anaemia in humans (Carmel and Spencer 1982), 
as already observed more than 25 years ago. In chicken, T3 is required by 
erythroblasts and sufficient to switch from sustained proliferation to terminal 
differentiation (Bauer, Mikulits et al. 1998). In case of human erythroblasts, T3 
improves terminal maturation (Figure 1.4), resulting in an increased percentage of 
enucleated cells after six days of differentiation. Additionally, T3 accelerates the rate 
of haemoglobin accumulation and improves synchrony of maturation, which means 
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that the mean cell size variation is reduced (Leberbauer, Boulme et al. 2005). 
Nevertheless, mice lacking thyroid hormone receptor alpha (TRα), thyroid hormone 
receptor beta (TRβ) or both, show no recognisable variations in standard 
haematopoiesis (Forrest, Erway et al. 1996; Fraichard, Chassande et al. 1997; 
Wikstrom, Johansson et al. 1998). 
In our culture system for human erythroid cells, also the addition of human serum is 
needed to promote successful differentiation. At present it remains unclear which 
serum factor is responsible for this effect. Thus, although the role of some factors 
essential for erythroid differentiation has become elucidated over time, apparently 
not all of them are identified yet.  
 
 
 
 
 
©Leberbauer et al 
 
Figure 1.4: Differentiation of human erythroblasts with and without T3 
In the presence of T3, the amount of enucleated cells increases significantly. 
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1.4 Cell-surface markers for haematopoietic progenitors 
 
To distinguish different maturation steps during haematopoiesis, cell surface 
markers can be used. There is a long list of different markers, especially for 
haematopoietic cells. Their names are mostly composed of the letters CD for 
“Cluster of Differentiation” and a number. 
Already in the 1980s, CD34 was described as a marker for HSCs (Ueda, Yoshida et 
al. 2001; Engelhardt, Lubbert et al. 2002). This glycoprotein is expressed on 1-5% of 
cells in the bone-marrow. It has been shown that CD34+ cells are able to form 
colonies in short term assays (Civin, Strauss et al. 1984) and keep this potential 
even in long term assays in in vitro culture (Sutherland, Eaves et al. 1989). 
Furthermore it was demonstrated that CD34+ cells are capable to repopulate 
immune-deficient mice (Bhatia, Wang et al. 1997). Despite these findings and the 
continuing wide-spread use of CD34 as an HSC marker, lately it has became clear 
that true HSCs are CD34-deficient (Bhatia, Bonnet et al. 1998). There is strong 
evidence that CD34- cells are more primitive than CD34+ cells (Nakamura, Ando et 
al. 1999; Engelhardt, Lubbert et al. 2002).  
Another frequently used marker for HSCs and early progenitors is c-Kit, the tyrosine 
kinase receptor for SCF, also called CD117. There is evidence that c-Kit is essential 
for HSC proliferation: SCF deficient mice have a 2.5-fold decrease in the absolute 
number of HSCs (Ikuta and Weissman 1992). Furthermore intraperitoneal injection 
of a c-Kit antagonist (anti-c-Kit) results in a dramatic reduction of HSCs and myeloid 
precursors in the bone marrow (Ogawa, Matsuzaki et al. 1991). 
After the transition of HSCs to multi-potent progenitors they, start to express lineage-
restricted markers like CD33 and CD38. The transmembrane-receptor CD33 is a 
marker for myeloid cells, whereas the glycoprotein CD38 is expressed on lymphoid 
cells.  
Ter 119 (mouse) and glycophorin A (GPA; human), frequently together with CD71 
(transferrin receptor) are well described erythroid markers, used to distinguish 
between immature, maturing and mature erythroid cells (Auffray, Marfatia et al. 
2001). 
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1.5 Thyroid hormone and its targets 
 
It remains unclear so far which molecular mechanisms cause the more mature 
phenotype of human erythroid cells differentiated in the presence of T3. mRNA 
expression profiling was performed to get a first idea of genes influenced by T3 
(Leberbauer et al, unpublished data). The used microarray chip included 1.176 
genes, 474 of which are expressed in erythroid cells. The profile was obtained from 
proliferating as well as differentiating cells at various time points (6, 30, 96 hours 
after induction of differentiation). Changes of gene expression, depending on time, 
were classified into four categories: “late up” (up-regulation after 30 hours), “early 
up” (up-regulation within the first 6 hours), “late down” (down-regulation after 30 
hours) and “early down” (down-regulation within the first 6 hours). Significant 
changes in expression caused by T3 could be observed for several genes which 
may be essential for differentiation (Figure 1.5). The data suggest that T3 plays a 
role in enucleation. An indication for that is the up-regulation of spectrin-beta (SPTB) 
and cytokeratine 2. T3 could also be needed for accelerated down-regulation of 
genes that repress erythroid differentiation, like IMP-dehydrogenase. The finding 
that caspase 3 (C3) is required for erythroid differentiation (Zermati, Garrido et al. 
2001) in connection to the observation that T3 represses caspase 7 makes the latter 
an interesting candidate for further investigation. 
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Figure 1.5: List of putative erythroid T3-targets 
A) To classify T3 induced changes in mRNA-expression four categories (“late up”, “early up”, “late 
down”, “early down”) were defined.  
B) Four of the putative erythroid target genes of T3 validated by induction of mRNA expression. One 
of them is the effector caspase C7. 
C) 12 genes on the array known to play a role in haematopoiesis showed a T3-induced repression, 
including the erythrocyte membrane protein spectrin ß. 
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1.5.1 Spectrin 
 
For their travel through the blood vessels red blood cells have to be elastic, flexible 
and equipped with good streaming properties. These features are almost due to one 
single protein: spectrin. Spectrin is the most abundant protein in the erythrocyte 
membrane skeleton, it makes up approximately 75% of its mass (Cohen 1983). This 
membrane protein in its simplest form is a heterodimer, consisting of two subunits: α 
(MW 240) and ß (MW 224) (Knowles, Marchesi et al. 1983) connected to each other 
at two positions. These heterodimers are linked by protein 4.1 and actin polymers to 
form a two-dimensional network (Figure 1.6). The chains of spectrin α and ß are 
antiparallel and both exhibit a repeating 106 amino acid long motif over most of their 
length that fold into a triple α-helical structure (Speicher and Marchesi 1984). The 
spectrin network lies on the cytoplasmic side of the erythrocyte membrane 
(Goodman, Krebs et al. 1988). The high affinity of the protein ankyrin with spectrin 
beta chains and the integral protein band 3 of the lipid bilayer result in the 
connection between the spectrin membrane and the cell membrane. 
Abnormalities in spectrin structure, quantity or function are associated with several 
inherited haemolytic anaemias in humans, including hereditary spherocytosis and 
elliptocytosis (Palek 1984; Becker and Lux 1985). Despite these erythrocyte shape-
changing variations, there are four known polymorphisms without any phenotype. 
Because of the ethnic origin of the used blood samples, we concentrated on spectrin 
type 1. Type 2, 3 and 4 are found exclusively in black people. 
During erythropoiesis, the synthesis of spectrin occurs in an asynchronous manner. 
Differentiated mouse erythroleukemia (MEL) cells, for example, accumulate spectrin 
in an amount comparable to that in mature red blood cells (Lehnert and Lodish 
1988). Human bone marrow cells from healthy donors, however, do not change their 
spectrin expression during erythropoiesis. It starts between the CFU-E and the pro-
erythroblast stage (Nehls, Zeitler-Zapf et al. 1993). 
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Figure taken from: “Molecular Biology of the Cell”, Alberts, Johnson, Walter, Lewis. Taylor & Francis. 2002 
 
 
Figure 1.6: Spectrin-based cytoskeleton of red blood cells 
Spectrin dimers together with ankyrin, actin and other components of the cell membrane cytoskeleton 
form a 2-dimensional meshwork, which lies beneath the plasma membrane. 
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1.5.2 Caspases 
 
Caspases are a group of evolutionarily conserved proteases found in nearly all 
animals from Caenorhabditis elegans to humans. The term caspase reflects the two 
key characteristics of this protein-family. They use cysteine as the nucleophilic group 
for substrate cleavage, therefore they are cysteine proteases. This is the basis for 
the letter “C”. “Aspase” refers to their ability to cleave after aspartic acids (Alnemri, 
Livingston et al. 1996). Caspases are key regulators of apoptosis, one of the most 
important biological programs. Apoptosis is essential for development and viability of 
multi-cellular organisms. Apoptotic cells are characterized for example by chromatin 
and nucleus condensation and cell body shrinkage (Zamzami and Kroemer 1999). 
These features are also observed on differentiating erythroid cells (Morioka, Tone et 
al. 1998). 
Caspases are synthesized as inactive precursors named procaspases. The 
formation of the two repeating heterodimeric catalytic domains of active caspases is 
carried out by proteolytic processing. On the basis of differences in procaspase-
structure, substrate specificity and kinetic data, caspases can be classified into 
initiators and effectors. Initiator-caspases function as activators of effector-caspases. 
At least one of these effector-caspases is affected by T3, namely caspase 7 (C7). It 
has been shown that some effector-caspases (C3, C6, C7) are transiently activated 
through erythroid differentiation and that they cleave proteins involved in nuclear 
integrity (lamin B) and chromatin condensation (acinus) without inducing cell death 
and cleavage of GATA-1 (Zermati, Garrido et al. 2001). GATA-1, a haematopoietic 
transcription factor, is essential for survival of progenitors and terminal differentiated 
erythroid cells (Ohneda and Yamamoto 2002). Reduced expression of C3 leads to 
incapacity of CD34+ cells to complete the transition from pro-normoblasts to 
basophilic normoblasts (Carlile, Smith et al. 2004). Interestingly, caspase inhibition 
delays erythroid differentiation (Kolbus, Pilat et al. 2002). 
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1.6 Aim of this work 
 
Although the constant supply of the body with mature erythrocytes is of essential 
importance, the molecular biological mechanisms during erythroid differentiation are 
not fully understood. Murine and human erythroid cell culture systems provided the 
basis for the study of these mechanisms. The human culture system, in contrast to 
the murine one, requires the use of serum during differentiation. One aim of this 
work was to remove specific constituents out of the serum and the performance of 
experiments in the presence of the obtained serum fractions. This should allow 
conclusions on the chemical character of essential differentiation factors within 
human serum.  
An already identified differentiation factor for human erythroid cells is thyroid 
hormone T3 (Leberbauer, Boulme et al. 2005). The second aim of this work was to 
show the power of T3 in the regulation of the two genes SPTB and C7 to validate 
data from mRNA expression profiling. Furthermore the design of shRNA constructs 
for the knock down of SPTB and C7 and their integration in lentiviral particles were 
additional goals in this work. Furthermore, the production and use of lenitiviruses 
should be established as a tool for down-knock of specific genes in erythroid cells 
during this diploma thesis. 
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2 Methods 
 
2.1 Cell Lines 
 
2.1.1 K-562 
 
Fresh cultures were started with 1x105 viable cells/ml, later the density was 
increased to 1x106 cells/ml. Medium (RPMI with 10% FCS; Sigma-Aldrich) was 
renewed every 2-3 days. Cells were propagated at 37°C with 5% CO2.  
Differentiation, characterized by haemoglobin accumulation and size-decrease, was 
induced with haemin (Lozzio and Lozzio 1975). 
 
2.1.2 MCF-7, Hela, HEK 293T & 293FT 
 
As basal medium Isocove’s Modified Dulbecco’s Medium (DMEM; Sigma-Aldrich) 
with 10% FCS was used. Cells were propagated at 37°C with 5% CO2.  
When the cells had reached a confluence of 80-90%, medium was removed. Cells 
were washed with PBS at room temperature. 1ml trypsin-EDTA was added and the 
mixture was incubated until the cell layer started to dispense. After addition of 9ml 
DMEM, cells were aspirated by gently pipetting. Aliquots of the suspension were put 
into new plates with the appropriate volume of medium. Usually the cells were split 
in a ration of 1:5 to 1:10. Medium was renewed every 2 to 3 days. 
 
 
 
2.2 Human & murine erythroid cell culture 
 
Umbilical cord and non-mobilized peripheral blood from healthy donors was 
collected in heparinised tubes (BD VacutainerTM) and stored at room temperature to 
prevent agglutination. Both peripheral and cord blood were processed within 24 
hours. 
Cord blood was originated from Caesarean sections, which took place in the period 
between May 2007 and June 2008 in the Division of Gynecological Endocrinology of 
the General Hospital, Vienna. 
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2.2.1 Isolation of mononuclear blood cells 
 
To remove mature erythrocytes, aliquots of blood were mixed well with 1x erylysis-
Buffer 1/25 (v/v) and incubated for 10-20 minutes at room temperature. During this 
time, lysis of red blood cells takes place. Because of that the suspension loses its 
viscosity and its colour turns from dark to light red. The mononuclear cells were 
collected by centrifugation at 250 g for 10min. The red supernatant was removed 
and the cell pellets washed 4-6 times with ice cold PBS (50ml 1xPBS, 250 g, 5min) 
to remove remaining non-lysed erythrocytes. After each washing step, 2-3 cell 
pellets were pooled. Finally, the pellet consists only of mononuclear blood cells and 
is almost white. Figure 2.1 shows a comparison between blood cells before and after 
this procedure. At the end the cell pellet was resuspended in an appropriate amount 
of 1xPBS. Cell concentration of this mixture was determined and the cells were 
seeded in proliferation medium at 5x106 cells/ml. 
 
 
 
 
 
Figure 2.1: Establishment of erythroid mass culture originating from umbilical cord blood 
A) Cell profiles with differences in mean cell size of blood cells before and after lysis and removal of 
erythrocytes. 
B) Peripheral blood smear shows mainly erythrocytes and one granulocyte (indicated by an arrow). 
C) Cytospin after erylysis shows mononuclear blood cells, i.e. granulocytes, monocytes and 
lymphocytes. 
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2.2.2 Determination of cell number & volume 
 
To monitor size and number of cultured cells, they were characterized daily with a 
CASYTM cell analyzer (Schärfe-System, Reutlingen, Germany). For this purpose, 
50µl of cell suspension were diluted 1:100 with CASYton (Schärfe-System, 
Reutlingen, Germany). An aliquot of 200µl of the mixture was measured. The 
obtained data were used to control the proliferation of both, primary cells and 
immortalized cell lines. 
 
 
2.2.3 Establishment of erythroblast mass cultures 
 
After lysis of erythrocytes, the cell suspension contains different types of 
mononuclear blood cells, mainly leukocytes (granulocytes, lymphocytes, monocytes) 
and thrombocytes. Human erythroblasts were expanded from cord and peripheral 
blood after removing erythrocytes within 10 days in serum free medium (StemSpan, 
Cell Systems) with following proliferation factors: 
 
• Epo 2 units (U)/ml Sigma-Aldrich 
• Dex 1µM Sigma-Aldrich 
• Igf1 40ng/ml Sigma-Aldrich 
• SCF 100ng/ml R&D Systems 
• Lipids 40µg/ml Sigma-Aldrich 
 
For the outgrowth of erythroblasts from peripheral blood two additional factors were 
added for the first six days: 
 
• human IL-6 10ng/ml Peprotech 
• human Flt3-L 50ng/ml Peprotech 
 
For the first 24 hours cells, were cultivated in medium with a double concentration of 
proliferation factors. During the following days, there is a mixed population of cells. 
From day 8 on the culture contains a homogenous population consisting 
predominantly of erythroblasts (Figure 2.1). Proliferation kinetics and size distribution 
were monitored daily using an electronic cell counter (see “Determination of cell 
number & volume”). Partial medium changes were performed every 24h to ensure 
optimal factor supply. This proliferation mix was not only used during initial 
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outgrowth of erythroid progenitors but also for long time culture. Once an 
erythroblast culture became visible, cells were cultivated at a density of 2x106 
cells/ml at 37°C, 5% CO2 and 100% humidity. 
 
2.2.4 Freezing erythroid progenitor cells 
 
10-50x106 cells were centrifuged at 250 g for 5 minutes. The pellet was re-
suspended in 900µl FCS. After that, 900µl of a mixture of FCS and 20% DMSO was 
added (final concentration of DMSO: 10%). DMSO protects the cell membranes 
during the freezing procedure. The cells were slowly cooled down by incubation at -
80°C in a styrofoam box and subsequently stored in liquid nitrogen. 
 
2.2.5 Thawing erythroid progenitor cells 
 
Frozen cell batches were quickly thawed in a 37°C waterbath. 10ml of medium 
without any factors or PBS were added drop by drop. After that, another 
centrifugation step at 250 g for 5 minutes was performed to remove all DMSO, which 
could be toxic to thawed cells. Cells were cultivated in StemSpan medium containing 
2x proliferation factors over night. Subsequently, the culture was handled as during 
establishment/expansion of erythroid mass cultures (see above). 
 
2.2.6 Induction of terminal differentiation of human erythroid cells 
 
To switch cells from proliferation to differentiation, the medium containing 
proliferation factors was removed by centrifugation (250 g, 5min). The pellet was 
washed with ice-cold PBS and resuspended in fresh medium containing 
differentiation factors: 
 
• Epo 10U/ml Sigma-Aldrich 
• Ins 4x10-4 IE/ml Actrapid HM 
• hTransferrin 10mg/ml Sigma-Aldrich 
• ZK 3x10-6M Schering Corp. 
• T3 1µM Sigma-Aldrich 
 
Because of size reduction of erythroid cells during differentiation, cells were 
maintained at a density of 3x106 cells per ml in differentiation medium. 
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2.2.7 Preparation of murine foetal livers 
 
We used wild type foetal livers at E11.5-13.5 as a source for murine erythroid 
progenitors. Pregnant mice were killed by cervical dislocation. To avoid 
contamination, the fur was sprinkled with 70% ethanol before the body wall was 
opened. After exposure of the peritoneum, the uterus was isolated and placed in a 
tissue culture plate containing ice cold PBS. The embryos were isolated and killed 
immediately by decapitation. The clearly visible foetal liver was taken after the 
removal of surrounding tissue and placed in a Stem-Pro-34TM (SFM, Invitrogen 
Gibco, 10639-011) containing tube. Foetal livers, collected from one pregnant mouse 
were homogenized by pipetting up and down. The medium was separated from the 
cells by centrifugation (250 g, 5min) and discarded. The pellet was resuspended with 
FCS and FCS/20% DMSO as described above (“Freezing of erythroid progenitor 
cells”). The suspension was filled into cryo-tubes so that every tube contained the 
equivalent of 1-2 foetal livers and stored like human erythroid cells.  
 
2.2.8 Outgrowth of murine erythroid progenitors 
 
Cells were quickly thawed in a 37° water bath, transferred to a 15ml-tube and 5ml 
medium or PBS was added. After centrifugation (250 g, 5min) and removal of the 
supernatant, collected cells were resuspended in medium enriched with growth 
factors: 
 
• Epo 2U/ml 
• SCF 100 µg/ml 
• Igf 1 40µg/ml 
• Dex 1µM 
 
The cells were seeded into tissue culture dishes and cultured at 37°C with 5% CO2. 
Partial medium change was performed every 24h, the cell density was adjusted to 2 
million cells/ml. 
 
2.2.9 Induction of terminal differentiation of murine erythroid cells 
 
Before terminal differentiation was induced, cells were purified using density gradient 
centrifugation. Through this procedure, spontaneously differentiated cells can be 
removed and a homogenous population of proliferating cells is obtained. After 
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another washing step with PBS, cells were reseeded (2x106 cells/ml) in Stem-Pro-
34TM, enriched with the following differentiation factors: 
 
• Epo 10U/ml 
• Insulin 10µg/ml 
• ZK 3x10-6 µM 
• hTransferrin 1mg/ml 
 
Murine erythroid cells were handled like human ones, which corresponds to daily 
partial media changes and maintenance of a cell-density of 3 million cells/ml.  
 
2.2.10 Ficoll-Hypaque gradient centrifugation 
 
Ficoll-Hypaque (lymphocytes separation medium, Eurobio) gradient centrifugation 
allows the removal of dead and spontaneously differentiated cells out of the culture. 
The purification should be done with 10-20x106 cells. The separation of the cell 
types takes place on different sedimentation density levels. Ficoll inserts into the cell 
membrane of dead and differentiated cells. Because of that, these cells sink to the 
bottom of the tube during centrifugation. 
The cell-suspension was transferred into a tube. 2ml Ficoll were layered under the 
medium. The gradient was centrifuged at 600 g for 7 minutes. Immature 
erythroblasts accumulating at the inter-phase between Ficoll and medium were 
collected. Dead and differentiated cells formed a pellet at the bottom of the tube. 
Erythroblasts were transferred into another tube, counted and washed with 1x PBS 
to remove Ficoll, centrifuged and cultivated as described. 
 
2.2.11 Photometric haem determination 
 
A reaction of O-phenylene-diamine dihydrochloride (Sigma-Aldrich) with haem is 
used to determine haem levels in erythroid cells (Kowenz, Leutz et al. 1987). 
3x50µl of cultured cells were transferred individually into 96well plates, centrifuged at 
250 g for 5 minutes and washed once with 100µl ice-cold 1x PBS. The pellet was re-
suspended in H2O for cell lyses. The plates were stored at -20°C until further 
processing. 
After thawing, lysates were incubated with 125µl haemoglobin-assay-dye-solution for 
three minutes. During incubation, the colour of the solution turns from clear to 
yellow. The reaction was stopped with 25µl 8N H2SO4. Haemoglobin concentration 
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was measured at a wavelength of 492nm using a 620nm filter as reference 
wavelength. For normalization of the haemoglobin levels, the obtained ODs were 
divided by cell-number and –volume. Relative haem levels were determined by 
using diluted chicken blood (1:3000) as standard. 
 
2.2.12 Histological staining of erythroid cells with benzidine 
 
To assess the condition of erythroid cells during different developmental stages, 
cells were centrifuged onto glass slides (150 g, 7min) and stained with histological 
dyes: DIFF red and blue (Fisher Scientific) for differentiation and O-diamisidine 
Meton (benzidine) for haemoglobin. 
 
 
Working step 
 
Time 
Incubation in methanol 4min 
Incubation in 1% benzidine solution 2min 
Incubation in H202 solution 1.5min 
Washing in H20 0.5min 
Stain with Diff Quick Red (I) 4min 
Stain with Diff Quick Blue (II) 40sec 
Rinse in water 
Dry with hair dryer or by air 
 
The stain was covered with mounting media (Entellan®, Merck) and an appropriate 
cover slip. 
 
 
2.3 Working with proteins 
 
To analyse changes in gene expression on the protein level, Western blot analysis 
(Burnette 1981) was performed. For this purpose, cell extracts of proliferating and 
differentiating erythroid cells were used. 5-10x106 cells were pelleted, washed once 
in 1x PBS, shock frozen in liquid nitrogen and subsequently stored at -80°C. 
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2.3.1 Total protein extract 
 
Depending on the size of the pellet, 20-50µl NP-40 lysis buffer was added. The 
solution was incubated for 3 minutes, vortexed and centrifuged for 2 minutes at 
14.000 g. The supernatant was taken for Western blot analysis and Bradford protein 
assay.  
 
2.3.2 Protein content determination with Bradford protein assay 
 
To measure protein concentration, 2µl of protein extract were added to 1 ml of 
Bradford solution (BioRad) diluted 1:5 in H2O. The mixture was set up in a plastic 
cuvette. The extinction at 595nm was measured against a blank only containing 
diluted Bradford solution. Protein concentration can be calculated using the formula: 
OD595nm 8.65 = Xµg/µl protein 
 
2.3.3 Protein content determination with SDS-Lowry 
 
The advantage of this assay is the usage of SDS: SDS separates membrane 
proteins from contaminating membrane constituents and denatures the proteins, 
resulting in better reproducibility. 
All glassware was washed with distilled water to remove detergents. A standard 
curve was prepared by adding 0, 5, 10, 15, 20 and 25µl of 0.1% BSA in water to the 
test tubes. 1ml of solution A was added to the cell extracts. The extracts were 
vortexed and incubated for 15 minutes at room temperature. After the addition of 
100µl of solution B, the mixture was immediately vortexed and incubated for 30 
minutes at room temperature. The extinction was measured at 650nm. 
 
2.3.4 Western blot analysis 
 
SDS gel electrophoresis 
Generally, a SDS-polyacrylamide gel consists of two parts: A lower part (resolving 
gel) and an upper part (stacking gel). The concentration of acrylamide of a resolving 
gel depends on the respective protein size. For resolving proteins between 30 and 
80kD, a 12% gel was used. For larger proteins, as for example SPTB, the 
percentage of acrylamide was decreased to 6%. 
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The cell extracts were mixed with 5x protein loading buffer and incubated at 95°C for 
five minutes to denature the proteins. The extracts were then separated on SDS-
polyacrylamide gels with 100-150V at 4°C for 1-1.5h.  
 
Western transfer 
Subsequently, protein was transferred to nitrocellulose membranes (0.2µm Protran, 
Schleicher & Schuell) with 250mA for 2 hours in Harlow transfer buffer at 4°C. 
Subsequently, membranes were stained in Ponceau S (Serva) for about 10 minutes. 
The resulting stain was scanned to assess equal protein loading. 
 
Antibody incubation 
To block unspecific antibody binding to the nitrocellulose membrane, it was 
incubated with 5% milk powder in 1x TBS containing 0.1% Tween-20 (TBS-T) for 1h 
at room temperature. The first antibody (Table 2.1) was diluted to the appropriate 
concentration and added to the membrane and incubated overnight (o/n) at 4°C. 
After 3 washing steps with 10ml TBS-T for 10 minutes each, the membrane was 
incubated with the appropriate second antibody (either for immuno-detection or 
infrared imaging) for 1h at room temperature. This was followed by another three 
washing steps with 1x TBS-T. 
 
Table 2.1: Concentrations of Western Blot Antibodies 
 
1st antibody 2nd antibody Block solution Wash solution 
Spectrin-ß 
1:10.000 
Anti mouse 
1:10.000 
TBS, 5% dry low 
fat milk 
TBS 0.2% Tween 
Caspase 7 
1:5.000 
Anti rabbit 
1:10.000 
TBS, 5% dry low 
fat milk 
TBS 0.2% Tween 
eIF4E 
1:10.000 
Anti rabbit 
1:10.000 
TBS, 5% dry low 
fat milk 
TBS 0.2% Tween 
 
 
Immuno-detection by chemoluminescence 
The membrane was transferred into a transparent plastic foil and incubated for one 
minute in equal amounts of enhanced chemoluminescence (ECL) solution 1 and 2 
(PerkinElmer). A light sensitive X-ray film (Fuji) was put in an exposure box together 
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with the membrane for appropriate time periods (20sec - 10min). The film was 
developed using a Curix 60 unit (Agfa). 
 
Protein quantification with infrared imaging 
The membrane was scanned on an Odyssey Infrared Imaging System. For 
quantification, Odyssey 2.1 software was used. 
 
2.4 Working with Bacteria 
 
2.4.1 Generation of chemically competent E. coli 
 
E. coli (Stable 3; Invitrogen) were grown as overnight 3ml culture in LB medium at 
37°C. 500ml SOB++ medium were added and the bacteria-culture was incubated at 
30°C until the absorbance at 600nm was approximately 0.5 (between 0.4 and 0.6). 
When the proper optical density was reached, the culture was chilled on ice for 30 
minutes. Bacteria were centrifuged in a pre-cooled Sorvall GSA rotor (4.500rpm, 
10min, 4°C). The supernatant was decanted and the pellet gently resuspended in 
100ml ice-cold TB buffer. The suspension was incubated for 30 minutes on ice, 
centrifuged in a pre-cooled Sorvall SS-34 rotor (3.000 rpm, 10min, 4°C) and 
resuspended in 18.6ml ice cold TB buffer. After that, 1.4ml DMSO were added. The 
cell suspension was incubated overnight on ice and subsequently aliquoted into 
sterile, pre-cooled Eppendorf tubes (400µl per tube) and shock frozen in liquid 
nitrogen. Chemically competent bacteria were stored at -80°C. 
 
2.4.2 Transformation of competent bacteria (heat shock) 
 
200µl chemically competent bacteria were thawed on ice and 10µl ligation solution 
added. After an incubation time of 30 minutes on ice, heat shock transformation was 
performed: The bacteria-ligation mixture was put into a 42°C warm water bath for 45 
seconds followed by chilling on ice for 2 minutes. 1ml SOB medium was added and 
bacteria incubated for 45 minutes with shaking at 37°C. The transformed bacteria 
were plated onto LB plates with appropriate antibiotics and incubated overnight at 
37°C. 
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2.5 Working with DNA & RNA 
 
2.5.1 Preparation of plasmid DNA 
 
A single bacterial colony was picked, inoculated into a starter-culture of 3ml LB 
containing the appropriate antibiotics and incubated over night at 37°C with shaking. 
For midipreps, the starter-culture was used to inoculate a 50ml main culture (LB + 
antibiotics), again grown over night at 37°C. Midipreps were worked up according to 
the QIAfilter® Midiprep Handbook (Qiagen). 
If a Miniprep was performed, 1.5ml of the overnight-culture were transferred into a 
2ml tube, centrifuged and further processed as described in the QuickLyse Miniprep 
Kit-Handbook (Qiagen). 
 
2.5.2 DNA Precipitation 
 
For removal of protein contaminations, the DNA solution was mixed with an equal 
volume of phenol (= TRIS-saturated phenol-chloroform-iso-amylalcohol), vortexed 
and centrifuged for 2 minutes at 12.000 rpm at 4°C. The supernatant was transferred 
to a fresh tube. Aspiration of the interlayer or organic phase was avoided. To remove 
phenol, an equal volume of chloroform was added to the phenol/DNA mixture. The 
mixture was vortexed and centrifuged for 2 minutes at 12.000 rpm at 4°C. The 
supernatant was transferred to a fresh tube. 0.1 volume of 3M sodium acetate and 
2.5 volumes of 100% ethanol were added. After vortexing, precipitation was 
performed either at -20°C overnight or -80°C for one hour. DNA was pelleted via 
centrifugation (20min, 12.000 rpm, 4°C) and washed with 1ml ice-cold 70% ethanol. 
The DNA pellet was air-dried for 10 minutes at room temperature, dissolved in H20 
and stored at -20°C. 
 
2.5.3 Enzymatic reactions 
 
2.5.3.1 DNA digestion with restriction endonucleases 
DNA-digestions were performed with restriction enzymes and their recommended 
reaction buffers (New England Biolabs). Usually, 1µg of DNA was cut with 5U 
enzyme at 37°C for 1-2h in a total volume of 20-100µl. The resulting DNA was 
precipitated in 96% EtOH, washed with 70% EtOH and then resolved in H2O (all 
reagents RNase free). 
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2.5.3.2 Ligation of DNA Fragments with T4 Ligase 
For ligation of DNA fragments, T4 ligase (Invitrogen) and the supplied 5x buffer were 
used. In general, a molar “vector to insert” ratio between 1:3 and 1:6, estimated from 
agarose gel electrophoresis, was applied. The total DNA amount was kept between 
10-50 ng for sticky end ligation. DNA was mixed with T4 5x buffer and 1µl (5U) of T4 
ligase enzyme in a total volume of 20µl dH2O. The reaction was incubated overnight 
at 16°C. 
 
2.5.4 Agarose Gel Eectrophoresis 
Agarose gels with 0.8-2% agarose in 1x TAE were prepared depending on the size 
of DNA fragments of interest. Agarose was melted in a microwave oven, cooled 
down, mixed with 0.5 mg/l ethidium bromide and poured into a gel tray. Prior to 
loading, the DNA solution was mixed with 6x DNA loading buffer and separated at 2-
8 V/cm. 
 
2.5.5 Excision and purification of DNA from agarose gels 
The DNA band of interest was excised with a clean scalpel under low-intensity UV 
light to avoid DNA damage and placed into a 1.5ml microcentrifuge tube. For DNA 
purification, Wizard® SV Gel and PCR Clean-Up System (Promega) was used. 
Excision and purification of DNA was performed according to the manufacturer’s 
guidelines. 
 
2.6 Working with lentiviral particles 
 
The used system for lentivirus production belongs to the 2nd safety generation and 
was generated at the Ecole Polytechnique Fédérale de Lausanne (Wiznerowicz and 
Trono 2003) and distributed by Addgene. 2nd generation vectors have a deletion of 
the packaging sequence and furthermore also of the 3’LTR. Because of that, two 
recombination events would have to take place simultaneously to generate a 
competent, “wild-type-like” virus. 
Therefore, three different vectors (Figures 2.1 and 2.2) are needed to produce viral 
particles: One, encoding Gag, for packaging (psPAX2), one envelope vector 
(pMD2.G) and of course a target vector (pLVTHM). 
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The mammalian vector pLVTHM allows direct cloning of shRNA (short hairpin RNA). 
For this purpose, the plasmid contains a single MluI site, which was used together 
with the ClaI site for inserting of shRNA-constructs (List 2.1). These constructs were 
designed with the Promega siRNA Target Designer (http://www.promega.com/ 
siRNADesigner/program/), checked for target-specificity via blast search and cloned 
into pLVTHM using the recommended restriction sites (MluI and ClaI). Restriction 
enzymes were obtained from New England Biolabs. 
 
2.6.1 Oligo annealing 
 
The corresponding forward and reverse DNA-oligonucleotides (Eurofins MWG 
GmbH) were dissolved in water to a concentration of 0.5µg/µl. 1µg of each 
oligonucleotide was added to the annealing buffer to a final volume of 20µl. After 
incubation at 80°C for 1 hour and slow cooling, annealed oligonucleotides were 
stored at -20°C. 
 
2.6.2 Production of lentiviral particles using calcium phosphate transfection 
 
24 hours before transfection, 3x105 293T or 293FT cells were seeded on six-well 
plates to reach about 70% confluency the next day. Two hours before transfection, 
medium was replaced by 2ml fresh preheated medium. 
 
For each well the following transfection mix was prepared: 
 
6.7µg pLVTHM (target vector) 
2µg pMD2G (envelope plasmid) 
5µg psPAX2 (packaging plasmid) 
20µl Ca2PO4 
H20 to a final volume of 167µl 
 
167µl 2x HBS were transferred into an Eppendorf tube. Transfection mix was added 
drop-wise to 2x HBS, simultaneously HBS was bubbled using a pipette boy with an 
extracted Pasteur pipette. After 5 minutes of incubation at room temperature, the 
HBS-DNA-mixture was added drop-wise to the cells and the plate rotated gently. 
16 hours after transfection, medium was changed. Transfection efficiency was 
determined by fluorescence microscopy (pLVTHM contains GFP). Supernatants 
were harvested every 12 hours, usually 2 or 3 times, and pooled. The lentivirus-
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containing supernatant was centrifuged at 300 g for 5 minutes to remove cell debris. 
The cleared supernatants were either used directly or stored at -80°C. 
 
2.6.3 Production of lentiviral particles with LipofectamineTM
 
24 hours before transfection, cells were seeded into six-well plates to reach 60-80% 
confluency the next day, using antibiotic-free medium. 10µl LipofectamineTM 
(Invitrogen) were mixed with 250µl OptiMEM medium (Invitrogen) and incubated for 
5min at room temperature. For each transfection, 4µg DNA (2µg pLVTHM, 0.5µg 
pMD2.G and 1.5µg psPAX2) were mixed gently with 250µl Optimem and added to 
the LipofectamineTM mix. After 20 minutes of incubation at room temperature, the 
DNA-LipofectamineTM mixture was added drop-wise to the cells, followed by gentle 
rocking of the plates. The transfection medium was removed after about 16 hours of 
incubation and exchanged by cell culture medium containing antibiotics. 
Determination of transfection efficiency, harvesting and storage of the lentivirus-
supernatant was performed as described above. 
 
2.6.4 Lentiviral infection of human cells using polybrene 
 
Adherent cells were seeded at the day before the infection into six-well plates, 
erythroid cells were centrifuged (250 g, 5min) and the supernatant removed. 
Lentiviral supernatant was thawed in a 37°C water bath and added to the adherent 
cells. Erythroid cells were resuspended in 300µl virus-supernatant, additionally 100µl 
of stem span medium with 4-fold growth factor concentration was added. 
Cells were incubated for 12 hours in the lentiviral supernatant. Polybrene (5µg/ml, 
Sigma-Aldrich) was added to the virus supernatant to allow the viral glycoproteins to 
bind more efficiently to their receptor on the cell surface. After incubation, the 
supernatant was removed and changed to the appropriate standard culture medium. 
 
2.6.5 Lentiviral infection of human cells using RetroNectin®
 
The use of RetroNectin® has the advantage that contaminating substances from the 
culture, which could affect the infection negatively, are removed from the virus 
solution. 
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Preparing of RetroNectin® coated plates: 
RetroNectin® lyophilized powder was dissolved in water by gentle swirling to a 
concentration of 1 mg protein/ml. The solution was filtered through a 0.22µl filter and 
stored at -20°C. Prior to coating, the solution was diluted with sterilized PBS to a 
concentration of 50µg Retronectin®/ml. 
2ml of diluted sterile RetroNectin® solution were dispensed into each well of a six-
well plate. The covered plate was allowed to stand for 2 hours. After this incubation, 
the RetroNectin® solution was removed and 2 ml of sterile PBS containing 2% 
bovine serum albumin (BSA) was added to each well for blocking. The BSA solution 
was removed after 30 minutes of incubation at room temperature and the wells were 
washed once with PBS. 
 
Gene transduction with the RetroNectin®bound virus (RBV) infection method 
Lentiviral supernatant was pre-loaded onto RetroNectin® coated plates and 
incubated for 5 hours at 37°C in a 5% CO2 incubator to promote attachment of virus 
particles to RetroNectin®. Virus-depleted supernatant was discarded and the plate 
washed with PBS to further remove undesirable substances originating from the 
supernatant. 
 
Viral infection 
Target cells were collected, counted, and suspended in growth medium at a 
concentration of 1x105 cells/ml. The suspension was added to the RetroNectin® 
coated plate immediately after removing of PBS. Cells were incubated for 2 days 
with 2x factor proliferation medium. 
 
2.6.6 Fixation of lentiviral-infected cells for flow cytometry 
 
1-5x105-cells were centrifuged at 250 g for 5 minutes, resuspended in 1ml of 4% 
para-formaldehyde (PFA) in 1x PBS and incubated for 30 minutes at room 
temperature. For FACS analysis, cells were centrifuged again (250 g, 5 min), 
washed once with PBS and resuspended in 500µl 1x PBS/FCS and transferred to 
FACS-tubes. Quantification of GFP-positive cells was performed as described. 
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2.7 Manipulation of human serum 
 
2.7.1 Dialysis 
 
Regenerated cellulose tubular membrane (ZelluTrans Roth) was cut into 15cm long 
pieces and boiled for 10 minutes in 1 liter 2% sodium bicarbonate with 1mM EDTA 
(pH 8). The tubing was rinsed thoroughly in distilled water and boiled again for 10 
minutes in 1l 1mM EDTA (pH 8). The tubing pieces were washed with distilled water 
inside and outside and used immediately.  
Human serum was dialysed for 72 hours against PBS. PBS was changed every 12 
hours. 
 
2.7.2 Fractionating of human serum using Vivaspin tubes 
 
Serum was transferred to Vivaspin tubes with a molecular cut-off of 30kD and 50kD 
and centrifuged for 30 minutes at 4.000 g. For differentiation assays, only the upper 
fraction was used. 
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3 Material 
 
3.1 Buffers & other solutions 
 
 
Solution 
 
Ingredients 
 
Additional information
 
100x haemin 
 
 
65mg haemin 
(Sigma-Aldrich) 
10ml 0,2M KOH 
1ml 0,2M Tris (pH 7,8) 
adjust pH to 7.8 with 1N HCl 
 
adjust pH to 7.8 with 1N HCl 
 
long-time-storage: -20°C 
short-time-storage: 4°C 
 
10x Erylysisbuffer 
 
 
89.9g ammonium chloride 
10g KHCO3
0.37g EDTA 
1000ml H20 
 
adjust pH to 7.3 
autoclave, dilute 1:10 with H20 
and filter sterilize 
store at room temperature 
 
10x PBS 
 
80g NaCl 
2g KCl 
11.5g Na2HPO4.2H2O 
 
H2O ad 1000ml 
 
store at room temperature 
      
1000x 3,3’,5-triiodo-
L-tyronine 
 
 
6.7µg tri-iodo-thyronine  
(Sigma-Aldrich) 
1ml 25mM NaOH 
 
dilute 1:1 with H20 and filter 
sterilize 
long time storage: -80°C 
short time storage: 4°C 
 
haem assay dye 
solution 
 
1 volume 0.1M citric acid 
1 volume 0.1M Na2HPO4 
0.5mg/ml o-phenylene-diamine-
dihydrochloride (DAPI, Merck) 
1µl/ml H2O2
8N H2SO4
1 volume concentrated H2SO4
3.6 volumes of H20 
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Benzidine staining solutions 
 
H202 solution 
 
75ml EtOH 
75ml H2O 
4,4ml H2O2
 
 
1% O-diamisidine 
Meton 
(benzidine) 
 
1g O-diamisidine Meton 
100ml dH20 
 
 
store light protected at -20°C 
 
 
50x TAE (pH 8.5) 
 
 
424g Tris Base 
57.1ml glacial acetic acid 
100ml 0.5M EDTA pH8 
 
 
Oligo Annealing 
buffer 
 
15mM Tris (pH 8) 
0.5M NaCl 
 
dissolve in dH20 
 
 
NP-40 Lysis Buffer 
 
 
25mM Hepes (pH 7.5) 
25mM Tris-HCl (pH 7.5) 
150mM NaCl 
10mM EDTA 
0.1% Tween20 
0.5% NP-40 
10mM Beta-Glycerophosphate 
 
 
 
 
SDS-Lowry solutions 
 
Solution A 
 
20ml 2% Na2CO3
20ml 1% CuSO4
50ml 20% SDS 
 
on the day of the assay: 
add 2% Na2CO3
 
Solution B 
 
Folin diluted with H20 at a 1:1 ratio
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Western blot solutions 
 
resolving gel 
 
 
2.5ml 1.5M Tris (pH 8.8) 
1.3-5ml 30% acryl amide  
50µl 20% SDS 
50µl 10% APS (fresh) 
5µl TEMED 
 
dH2O ad 10ml 
 
(the amount of acryl amide 
depends on the respective 
protein size) 
 
stacking gel 
 
 
3ml H2O 
1.25ml 0.5M Tris (pH 6.8) 
650µl 30% acryl amide 
25µl 20% SDS 
25µl 10% APS (fresh) 
5µl TEMED 
 
 
30% acryl amide  
 
 
150g acryl amide 
4g N,N-methylen-bis-acryl amide
 
H2O ad 500ml 
 
5x SDS 
electrophoresis 
Buffer 
 
30.2g Tris 
188g glycin 
1.800ml dH2O 
100ml 10% SDS 
 
H2O ad 2.000ml 
 
1x Harlow transfer 
buffer 
 
 
5.8g Tris 
29g glycin 
1.600ml H2O 
400ml methanol 
 
Harlow transfer buffer can be re
used up to 3 times 
store at 4°C 
 
 
10x Ponceau 
 
 
2g Ponceau S 
30g tri-chlor-acetic acid 
30g sulfosalicylic acid 
 
 
H2O ad 100ml 
 
10x TBS 
 
 
100ml 1M Tris (pH 8) 
300ml 5M NaCl 
 
H2O ad 600ml 
 
TBS-T 
 
 
500ml 1x TBS 
2.5ml 20% Tween20 
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LB medium 
 
 
20g/l bacto-tryptone 
5g/l yeast extract 
5g/l NaCl 
 
 
 
TB buffer 
 
 
10mM HEPES (pH 6.7) 
15mM CaCl2 
250mM KCl 
adjust pH to 6.7 with KOH 
55mM MnCl2 
 
 
 
filter sterilize the mixture using 
0.22µl filter 
 
SOB++ medium 
 
 
20g/l bacto-tryptone 
5g/l yeast extract 
0.5g/l NaCl 
0.186g/l KCl 
10mM MgCl2 
10mM MgSO4 
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3.2 shRNA constructs 
 
3.2.1 shRNA constructs for caspase 7 
 
casp7_01-a (s) 
CGCGT CCCC GGGCAAATGCATCATAATA TTCAAGAGA TATTATGATGCATTTGCCC TTTTT GGAA AT 
casp7_01-b(as) 
CGA TTTCCAAAAA CCCGTTTACGTAGTATTAT AAGTTCTCT ATAATACTACGTAAACGGG GGGGA   
 
casp7_02-a (s) 
CGCGT CCCC GGGCAAATGCATCATAATA TTCAAGAGA TATTATGATGCATTTGCCC TTTTT GGAA AT 
casp7_02-6(as) 
CGA TTTCCAAAAA CCCGTTTACGTAGTATTAT AAGTTCTCT ATAATACTACGTAAACGGG GGGGA 
 
casp7_03-a (s) 
CGCGT CCCC GGGCAAATGCATCATAATA TTCAAGAGA TATTATGATGCATTTGCCC TTTTT GGAA AT 
casp7_03-b(as) 
CGA TTTCCAAAAA CCCGTTTACGTAGTATTAT AAGTTCTCT ATAATACTACGTAAACGGG GGGGA 
 
casp7_04-a (s) 
CGCGT CCCC GGGCAAATGCATCATAATA TTCAAGAGA TATTATGATGCATTTGCCC TTTTT GGAA AT 
casp7_04-b(as) 
CGA TTTCCAAAAA CTCACTCGACTCTGTCTAT AAGTTCTCT ATAGACAGAGTCGAGTGAG GGGGA 
casp7_05-a (s) 
CGCGT CCCC GTCTGTTACCTTGTTAATA TTCAAGAGA TATTAACAAGGTAACAGAC TTTTT GGAA AT 
casp7_05-b(as) 
CGA TTTCCAAAAA CAGACAATGGAACAATTAT AAGTTCTCT ATAATTGTTCCATTGTCTG GGGGA 
 
c7_scramb-a 
CGCGT CCCC ACTGTCTAACGTTTTATT TTCAAGAGA AATAAAACGTTAGACAGTC TTTTT GGAA AT 
c7_scramb-b 
CGA TTTCCAAAAA TGACAGATTGCAAAATAA AAGTTCTCT TTATTTTGCAATCTGTCAG GGGGA 
 
 
3.2.2 shRNA constructs for spectrin ß 
 
spec-ß_01-a (s) 
CGCGT CCCC GCCGCATCACCGATCTCTA TTCAAGAGA TAGAGATCGGTGATGCGGC TTTTT GGAA AT 
spec-ß_01-b(as) 
CGA TTTCCAAAAA CGGCGTAGTGGCTAGAGAT AAGTTCTCT ATCTCTAGCCACTACGCCG GGGGA 
 
spec-ß_02-a (s) 
CGCGT CCCC GACTGAGAAGATGATTGAA TTCAAGAGA TTCAATCATCTTCTCAGTC TTTTT GGAA AT 
spec-ß_02-b(as) 
CGA TTTCCAAAAA CTGACTCTTCTACTAACTT AAGTTCTCT AAGTTAGTAGAAGAGTCAG GGGGA 
 
spec-ß_03-a (s) 
CGCGT CCCC GTGTACACCTGGAGAACAT TTCAAGAGA ATGTTCTCCAGGTGTACAC TTTTT GGAA AT 
spec-ß_03-b(as) 
CGA TTTCCAAAAA CACATGTGGACCTCTTGTA AAGTTCTCT TACAAGAGGTCCACATGTG GGGGA 
 
spec-ß_04-a (s) 
CGCGT CCCC GCAGGCTACCCTCATGTTA TTCAAGAGA TAACATGAGGGTAGCCTGC TTTTT GGAA AT 
spec-ß_04-b(as) 
CGA TTTCCAAAAA CGTCCGATGGGAGTACAAT AAGTTCTCT ATTGTACTCCCATCGGACG GGGGA 
 
spec-ß_05-a (s) 
CGCGT CCCC GCATCACCGATCTCTACAA TTCAAGAGA TTGTAGAGATCGGTGATGC TTTTT GGAA AT 
spec-ß_05-b(as) 
CGA TTTCCAAAAA CGTAGTGGCTAGAGATGTT AAGTTCTCT AACATCTCTAGCCACTACG GGGGA 
 
spec_scramb-a 
CGCGT CCCC GCATCACCGATCTCTACAA TTCAAGAGA TTGTAGAGATCGGTGATGC TTTTT GGAA AT 
spec_scramb-b 
CGA TTTCCAAAAA CGTAGTGGCTAGAGATGTT AAGTTCTCT AACATCTCTAGCCACTACG GGGGA 
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3.3 Maps of used plasmids 
 
 
Maps taken from: www.addgene.org 
Figure 3.1: Map of pMD2.G 
pMD2.G is needed to envelop the virus DNA in the producer cells (envelope plasmid) 
 
 
 
 
 
Map taken from: www.addgene.org 
Figure 3.2: Map of psPAX2 
psPAX2 is a high-copy 2nd generation packaging vector recommended for lentivirus production. 
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Map taken from: www.addgene.org 
Figure 3.3: Map of pLVTHM 
The vector pLVTHM contains two ClaI sites: one is used for direct cloning of shRNA, the other one is 
blocked via Dam methylation. Because of that it is necessary to use Dam+ bacteria strains for 
plasmid propagation. 
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4 Results 
 
4.1 Outgrowth & proliferation of erythroid progenitors 
 
In this diploma thesis, outgrowth, proliferation and differentiation of erythroid 
progenitors were carried out in the specific serum-free media StemSpan (for human 
cells) and Stem-Pro-34 (for murine cells). Sources for erythroid progenitors were the 
murine foetal liver as well as human umbilical cord and unmobilized peripheral 
blood. The performance of the progenitor cells differ, depending on their origin 
(Figure 4.1.1 & 4.1.2). Whereas the culture system of human cells starts with the 
removal of erythrocytes to obtain mononuclear cells, murine foetal liver cells require 
no further preparation after their harvest and homogenization in medium. During the 
first days of cultivation, however, murine cultures have a tendency to differentiate 
spontaneously. To obtain a homogenous immature erythroblast cell population, a 
purification step is needed. In the human system such a purification step is not 
required and establishment of a homogenous erythroblast population occurs simply 
by outgrowth of progenitors triggered with the appropriate growth factors. As 
peripheral blood contains much fewer CD34+ cells than cord blood, the yield of 
erythroblasts proportional to the used amount of blood is smaller. To improve the 
outgrowth of erythroid progenitors from peripheral blood, cultures receive Flt3 and 
IL-6 for the first 6 days in addition to the other factors. Casy cell counter size profiles 
and cytospins illustrated the differences in outgrowth and composition of the different 
culture types (4.1.2.B). Due to the absence of haemoglobin in proliferating cells, the 
cytosol appears blue to violet after staining. Red-brownish staining is the result of a 
reaction of benzidine with haemoglobin. The cytospins of murine foetal liver cells 
after 4 days in culture show haemoglobinized cells, which were removed by gradient 
centrifugation. After this purification step, the cultures consisted almost exclusively of 
proliferating erythroblast (Figure 3.1). 
During proliferation, DNA has to be replicated incessantly. Therefore the nucleus is 
relatively large. This could be observed in human as well as murine erythroid cells. 
Casy-profiles illustrate the differences in cell size of murine versus human immature 
erythroblasts: murine cells (approx. 9µm diameter) are smaller than human ones 
(approx. 11µm). 
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Figure 4.1: Establishment of murine erythroid mass cultures 
Cells were cultivated as described in “Methods”. Cell numbers and volumes were determined daily 
with an electronic cell analyser. During the first days, the cultures are heterogenous. After 4 days, the 
amount of erythroblasts had increased significantly in the culture. Spontaneously differentiated cells 
were removed by density gradient centrifugation. Cytospins were stained with benzidine to reveal 
haemoglobin. 
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Figure 4.2: Establishment of human erythroid mass culture 
Cell volume changes in cord blood derived (A) and peripheral blood (B) derived erythroid cell 
culture were monitored daily with an electronic cell analyser. Cells were cyto-centrifuged onto 
glass slides and stained with cytological dyes. During the first few days, multiple cell types like 
macrophages, leukocytes and only few erythroblasts are present. The proportion of the latter 
increases upon cultivation in specific erythroid factors (Epo, Dex, SCF, and IGF-1). At day 12, the 
majority of cells in the rapidly proliferating cultures shows an erythroblast phenotype.  
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4.2 The effect of testosterone on human erythroblasts 
 
To check if there is any effect of steroid hormones on erythroid cells in our culture 
system, dihydro-testosterone (DHT) and progesterone were added to proliferating 
erythroblasts (Figure 3.1). Both hormones were added to the cells at a concentration 
of 1µM. The erythroid cells used had already been in culture for at least 10 days 
before starting the addition of hormones. 
Erythroblasts expanded from male donors showed no difference in their proliferation 
rate after treatment with DHT or progesterone compared to the negative control. The 
calculation of cumulative cell numbers from female-derived erythroblasts showed no 
response to steroid treatment during the first five days of the experiment. From 
about day 6 (culture day 16) on, a proliferation-promoting effect of DHT was 
observed in female erythroblasts. 
 
 
 
 
Figure 4.3: The influence of steroid hormones on human erythroid proliferation 
Cell numbers from cultures of male (A) versus female (B) cord blood donors (pre-grown for 10 days in 
the absence of sex steroids) were counted daily in an electronic cell counter and cumulative cell 
numbers were determined. Cells were cultivated either under standard proliferation conditions 
(yellow), or in the presence of 1 µM testosterone (blue) or in the presence of 1µM progesterone (red). 
51 
 Results 
 
4.3 Terminal differentiation of erythroid progenitors 
 
Differentiation was induced in human cells on culture day 14 and lasted 6 days 
(Figure 3.2 – upper & middle panel). During this time, cells had shrunk in size from 
about 11 to 7.5µm (Figure 3.2.A). This size reduction was also observed on 
cytospins, which illustrated furthermore the condensation of the nuclei (Figure 
3.2.B). After 72 hours of differentiation, human erythroid cells were already 
massively haemoglobinized. The increase of the haem synthesis rate was not linear 
and reached its maximum after a rapid progression between 69 and 120 hours of 
differentiation (Figure 3.2.C).  
The same trends were observed in differentiating murine erythroblasts (Figure 3.2.A 
– bottom panel). Benzidine staining of cytospins (Figure 3.2.B) clearly illustrated the 
accumulation of haemoglobin during the process of maturation, indicated by the red-
brownish staining of the cytosol. Besides haemoglobin production, morphological 
changes take place as well. The nuclei of proliferating cells are relatively large. This 
did not change during the first 24 hours after initiation of differentiation. First 
alterations in phenotype were observed after 48 hours in differentiation medium. 
Both murine and human cells showed strong reduction in cell size, massive 
condensation of nuclei and accumulation of haemoglobin. In addition, one of the final 
and most striking events during erythroid differentiation, the extrusion of nuclei could 
in some cells already be observed after 48 hours of differentiation. 
At 72 hours, most changes accompanying terminal erythroid development were 
almost completed in murine cells. The nuclei were maximally condensed and 
approximately 30% of the cells were already enucleated. Under the culture 
conditions for murine erythroid cells, haem-synthesis reached its maximum after 48 
hours of differentiation (Figure 3.2.C – bottom panel). Data from haemoglobin-
assays and Casy cell size measurements underlined the visible morphological 
changes visible in cytospins. After enucleation, the mean cell size of murine 
erythroid cells reached values around 6µm. 
As indicated by all used assays murine erythroblasts differentiated faster and with 
respect to enucleation also more efficiently than human erythroblasts in vitro.  
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Figure 4.4: Terminal differentiation of murine and human erythroid cells 
A) Cell numbers and cell volumes of differentiating human cord blood and peripheral blood derived 
cells as well as murine foetal liver derived cells were monitored daily with an electronic cell 
counter. 
B) Differentiated cells were cyto-centrifuged onto glass slides and stained with cytological dyes. 
C) Haemoglobin accumulation was determined by a photometric assay during differentiation every 
24 hours in case of human cells and every 12 hours in case of murine cells.  
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4.4 Terminal differentiation of human erythroid cells with different 
 fractions of serum 
 
Until now it remained unclear which additional factor(s) in the serum promote human 
erythroid cell differentiation and inhibit proliferation. In our human cell culture system 
3% human serum is needed to promote erythroid cell maturation in a synchronous 
and efficient manner. To get a first indication what kind of factor or factors are 
responsible for this observation, serum was dialysed to obtain samples of different 
average molecular weight.  
Figure 3.1.A depicts CasyTM profiles of human erythroid cells from umbilical cord 
blood differentiating for 6 days. The development of cells differentiated with whole 
serum (orange) and the one of erythroblasts treated with dialysed serum without 
components smaller than 3kD (light green) were quite similar. Both profiles showed 
homogenously differentiated cell populations with a mean cell size of 7.5µm. All 
other profiles showed a broader peak, indicating inefficient differentiation. Compared 
to the positive control, there were more cells bigger than 7.5µm, corresponding to 
more immature cells. In addition, there was also a population of particles smaller 
than 7.5µm, representing dead cells and cell components. As negative control, 
(yellow) another culture was kept in the absence of any serum. The mean size of 
these cells shifted to the left compared to differentiation in serum-containing 
medium. 
The corresponding cytospins supported the trends indicated by the Casy profiles. 
Cells differentiated with full serum (orange framed) showed strongly 
haemoglobinized cells. The depicted section shows two enucleated cells with one 
extruded nucleus. The development of cells differentiated in the presence of the 
dialysed serum fraction with a cut off of 3kD (light green framed) was comparable to 
the positive control: it contained strongly haemoglobinized cells with properly 
condensed and sometimes even extruded nuclei. The cell shown in the middle has 
its nucleus already located at the cell periphery, apparently entering the process of 
enucleation. The other cytospins show exclusively nucleated cells and cell 
fragments. 
The most striking difference caused by the serum fractions used became apparent in 
the differences of the haem synthesis rates. During the first 72 hours of 
differentiation, erythroblasts exhibited comparable rates of synthesis. The first slight 
54 
 Results 
 
aberration appeared after 96 hours in the presence of different serum fractions. 
Erythroid cells differentiated with sera dialysed with a bigger cut off than 3kD had no 
higher elevation of haem levels after 120 hours. A comparable performance was 
observed in cells maturing in the absence of serum. The haem synthesis rates of 
cells with complete serum and those receiving dialysed serum (cut-off 3kD), 
however, reached its maximum after 120 hours of differentiation. Furthermore, they 
showed the characteristic accelerated increase of haemoglobin levels between 96 
and 120 hours.  
 
 
 
 
4.5: Differentiation with diverse fractions of human serum 
Human serum was depleted from constituents smaller than 50kD (dark blue) and 30kD (light blue) by 
centrifugation with Vivaspin tubes. For the removal of constituents smaller than 6kD (dark green) and 
3kD (light green) dialyses tubes with appropriate molecular cut-off were used. Cord blood-derived 
erythroid progenitors were differentiated in the presence of these different serum fractions. As 
positive and negative controls, respectively, cells were differentiated either with full serum supply or in 
the absence of any serum. Erythroblasts differentiated for 6 days show differences in mean cell size 
distribution (A) and in the degree of differentiation (B). 
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4.6: Differences in haem-synthesis rates caused by the use of different serum fractions 
Haem levels of differentiating cells were determined by colorimetry (see methods). During the first 72 
hours of differentiation, there was no difference in haem synthesis rates of erythroblasts due to the 
diverse serum fractions. First effects became visible after 96 hours. By 120 hours, haem levels of 
erythroblasts differentiated with full serum and with serum dialysed with a cut off of 3kD was 
approximately 3 times higher than that of all other samples. 
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4.5 Haemoglobin negatively influences optical density 
 measurement of protein concentration 
 
The increasing amount of haemoglobin in differentiating cells causes problems with 
optical density (OD) measurements (Figure 4.3.1.B). Because of this observation we 
compared two different methods. First, the reliability of values obtained with Bradford 
and SDS-Lowry was tested. Figure 4.3.1.A depicts the comparison between the 
values obtained with these two protocols using specific amounts of BSA (0.1%). 
With SDS-Lowry an almost linear increase of OD-values was observed. Data 
obtained with the Bradford reagent had a stronger increase with BSA amounts lower 
than 15µl as compared to above this amount of BSA. In the determination of total 
protein amount in samples of proliferating and 6 days differentiated erythroid cells 
both measurements failed (Figure 4.3.1.B). Cell extracts separated by gel 
electrophoresis demonstrated that the amount of loaded protein was not comparable 
between the two growth conditions. The proliferation samples contained multiple 
protein bands in comparison to the differentiation sample, where haemoglobin 
dominates the mixture. After that a Bradford correction factor was determined for 
adjustment of aberrant raw data. We used increasing sample amounts referring to 
the increase of haemoglobin during differentiation. After that it was tested which 
amounts would result in comparable band intensities in Western blots using 
immuno-detection of eIF4E, which is known to stay at the same absolute abundance 
under the various conditions (Figure 4.3.1.C). For the sample with 2 days 
differentiated cells 20% (x 1.2) more extract volume was loaded than determined 
from Bradford OD measurements, 40% more (x1.4) for 4 days and 80% more (1.8) 
for 6 days.  
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Figure 4.7 Correcting the amount of protein from erythroid cells for Western blotting 
A) OD values of different amounts (5 to 25µl) of 0.1% BSA were measured with Bradford and Lowry 
assays and a standard curves was generated. 
B) Western blotting was performed with proliferating (P) and terminally differentiating cord blood-
derived erythroid cells (d6). The amount of protein was defined either with Bradford (left, blue) or 
SDS-Lowry (right, green). 
C) For the adjustment of the inherent “erythroid” error in OD measurements caused by increasing 
amounts of haemoglobin, comparable amounts of protein were obtained by inclusion of “Bradford 
correction factors” based on experimental data.  
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4.6 Expression of Caspase 7 & Spectrin ß in erythroid cells is 
 influenced by T3  
 
Because of the promising results from the mRNA expression profiling and the known 
functions of C7 and SPTB in erythroid cells, the expression patterns of these two 
proteins were analyzed by Western blotting. First, differentiation was induced with 
two different media, one containing T3, the other without the hormone. For Western 
analyses, corresponding cell pellets were used, together with an additional one from 
proliferating starting culture as internal control. The C7 expression in erythroid cells 
differentiated without T3 decreased during the first 48 hours of differentiation, stayed 
rather constant thereafter and exhibited a strong increase at the last time point. Cells 
which were differentiated in the presence of T3 had another expression pattern: after 
the first 24 hours, during which no significant difference between the T3-treated and 
non-treated cells was observed, C7 expression went up about 3-fold after 96 hours 
of differentiation. At the end of differentiation, T3 treated cells showed a decrease of 
C7, reaching an amount below that of untreated cells (Figure 4.4.1). 
SPTB is not present at detectable abundance in proliferating erythroblasts. Its 
amount increases constantly during differentiation, both in hormone-treated and non-
treated erythroid cells. T3-treated cells, however, had a faster and more pronounced 
increase in SPTB expression than non-treated ones. 
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Figure 4.8: Expression of C7 & SPTB during erythroid differentiation 
C-7 and SPTB protein expression levels during differentiation of T3 treated and non-treated cells 
were determined, eIF4e was used as loading control. For Western Blot (A) proliferating and 
differentiating cells of different time points (24h, 96h, 144h) were used. B shows the quantification of 
the signals shown in A. The graph illustrates the changes of the protein levels during differentiation of 
eryhthroblasts. 
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4.7 Caspase 7 & Spectrin ß expression in human cell lines 
 
After validation of the mRNA expression profiling concerning C7 and SPTB in cord 
blood derived erythroid cells, we tried to find human cell lines which also express the 
genes of interest to validate the function of corresponding sh-RNA constructs. The 
use of cell lines was expected to be both, time and cost saving. 
In a first step, the expression pattern of C7 and SPTB was assessed in HeLa, 293T 
and Mcf-7 cells (Figure 4.4.1.A). Especially the latter showed strong expression of 
C7. None of these cell lines, however, express any detectable SPTB. 
Thus, in a second step differentiation was induced in the erythroid cell line K-562 
using haemine. The cells started to accumulate haemoglobin (Figure 4.4.1.B) and 
showed a decrease in cell size (Figure 4.4.1.C). To proof whether this clear 
evidence for differentiation also had an effect on SPTB expression the Western blot 
analysis was repeated (Figure 4.4.1.D). As positive control 3 days differentiated 
primary erythroid cells were used. Also K-562 erythroleukaemic cells did not show 
any expression of SPTB during differentiation, possibly owing to their transformed 
phenotype precluding expression of late erythroid proteins. 
 
 
 
 
 
 
 
Figure 4.9: Expression of C7 & SPTB in human cell lines 
Western blots presenting the expression of C7 and SPTB in proliferating cord blood-derived 
erythroblasts (CB) and different human cell lines (HeLa, 293T, MCF-7). The amount of loaded protein 
was estimated with Bradford assay.  
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Figure 4.10: Characterization of K-562 differentiation 
A) Differentiation of K-562 cells was induced with haemin. The accumulation of haemoglobin was 
determined by a photometric assay as described above. 
B) The cell size of differentiating K-562 cells was monitored daily with a CASYTM cell analyzer. 
C) Western blot showing the expression of SPTB in cord blood derived erythroid cells differentiated 
for three days versus proliferating and differentiating K-562 cells at various time points (24h, 72h, 
120h). Neither in proliferating nor in differentiating K-562 cells SPTB expression could be 
observed. 
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4.8 Lentiviral infection of human erythroid cells 
 
For the production of lentiviral particles we used either LipofectamineTM or Calcium 
Phosphate. The transfection efficiency was determined with luminescence 
microscopy and generally resulted in about 90% green-luminescent cells. However, 
there were big differences in the infectiousness of the obtained lentiviral 
supernatants, which ranged from about 5 to 20% infected cells. Differences caused 
by the different transfection methods were not observed. Figure 4.5.1 shows 
infection (transfection with LipofectamineTM), which results in the highest amount of 
infected erythroblasts.  
Despite these low infection rates we performed western blot analyses (Figure 
4.5.2.A) and induced differentiation (Figure 4.5.3.C). In western blot we could not 
detect any reduction of C7 expression. Cell profiles of proliferating infected 
erythroblasts (Figure 4.5.3.B) and the negative control (uninfected cells) show no 
significant differences. The peak of the uninfected cells of the negative control was 
slightly broader compared with the infected erythroblasts. Furthermore there was no 
difference in the performance of differentiation between infected erythroid cells and 
control cells detectable in the cell profiles. 
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Figure 4.11: Efficiency of lentiviral infection of human erythroblasts 
For lentiviral infection cord blood-derived erythroid cells were incubated for 12 hours with lentiviral 
supernatants containing 5µg/ml polybrene and medium with growth factors. The infection rate was 
determined by flow cytometry. All cells above the bold grey line are classified as GFP positive, 
respectively infected. 
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Figure 4.12: Cell profiles of lentiviral infected eryhroblasts 
A) Western blots of lentivirally infected erythroblasts showed no knock down of C7 protein 
expression. 
B) Cell number and size of lentivirally infected proliferating erythroblasts were monitored with an 
electronic cell counter. 
C) Differentiation of infected and uninfected erythroblasts was comparable. 
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5 Discussion 
 
5.1 Features of the human cell culture system: DHT & serum 
 
During the last decades, culture systems for HSC contributed to a number of 
findings in diverse haemotopoietic conditions, like quiescence, commitment to 
special lineages, maturation and apoptosis. Key signalling pathways and essential 
factors for HSC maintenance were described improving the techniques for 
haematopoietic in vitro cultures. In this thesis we used different sources for HSCs of 
both murine and human origin. The human cell culture conditions were based on the 
mouse cell system (Dolznig, Boulme et al. 2001) and adapted to the special needs 
of human erythroid progenitors (Leberbauer, Boulme et al. 2005). First, we used 
different media for murine and human cells. Second, the factor-mix for proliferating 
human erythroid progenitors was enriched with lipids, which prolongs proliferation 
and survival of the cells from 30 to 60 days. The addition of lipid alone was not 
efficient to cultivate the desired number of erythroid cells from peripheral blood. The 
abundance of erythroid progenitors in peripheral blood is much lower than in 
umbilical cord blood. Outgrowth of erythroid progenitors from peripheral blood 
needed further support via IL-6 and Flt 3. Furthermore, in the cell culture system 
described here, human cells needed human serum during differentiation. Serum 
improved proliferation and also acted in protection against apoptosis. 
One observation in human cord blood-derived erythroblasts was a sex-specific 
proliferation-promoting effect of DHT. This was only observed in female erythroid 
cells. It is obvious that sex-specific differences in all relevant blood parameters exist. 
One of the main indicators is the amount of cellular components in the blood volume, 
the haematocrit. It mainly results from erythrocytes, which are the most abundant 
cell type in blood. The haematocrit level of healthy women ranges from 4–5.5x106/µl, 
whereas the level in healthy men ranges from 4.5–6x106/µl. Corresponding to 
haematocrit levels, there is a difference in the amount of erythrocytes: 35–40 Vol.% 
(women) and 40–50 Vol.% (men). In addition to these general variations, anaemia 
caused by iron deficiency affects predominantly females. One reason for this is a 
loss of iron during menstruation and giving birth. Up to 20% of the female population 
in Austria is affected by sub-acute anaemia and the concurrent general fatigue. One 
of the reasons why men have higher amounts of erythrocytes and a lower risk to 
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develop anaemia could be explained by an erythropoietic potency of androgens, the 
male steroid hormones. It has been shown that females treated with DHT reach 
haematocrit levels similar to males (Fried and Gurney 1968). The increase of blood 
cells observed in vivo and in vitro, could be caused through accelerated erythroid 
differentiation or increased proliferation of HSCs or haematopoietic progenitors. The 
proliferation-promoting effects were observed exclusively in female erythroblasts. If 
DHT had a general erythropoietic potency, this effect would be expected to occur in 
cells of both sexes.  
The fact that human erythroblasts in our cell culture system needed the presence of 
serum for differentiation pointed out the complexity of erythroid differentiation. 
Consuetudinary cell culture is performed in the presence of serum (Panzenbock, 
Bartunek et al. 1998). Under our culture conditions, the cells accumulated more 
haemoglobin and showed a higher and more synchronous size decrease in the 
presence of serum. Furthermore, serum seemed to prevent apoptosis. The use of 
serum is suboptimal, however, for various reasons: It contains still unidentified 
factors, which drive cells to differentiation. Furthermore, the concentration of the 
serum constituents may differ from batch to batch, because of that essential factors 
could not be controlled. 
To get a first indication what kind of factors within serum might play the described 
crucial role during differentiation, serum-constituents were removed depending on 
size, for example by dialysis. The results suggested that one or more relevant 
factors for differentiation have a size between 3 and 6kD. Although efficiency of 
removal of components by dialysis is influenced not only by the size of constituents 
but also by chemical attributes, these possible side-effects were avoided by long 
dialysis times.  
It is presumed that serum contains both differentiation promoting and inhibiting 
factors. It could be that the most important factors with these diverse functions are in 
the same size range. Another possibility is a different balance of promoting and 
inhibiting factors in the serum fractions. If there were factors essential for the 
maintenance of cells in the size range between 3 and 6kD, effects caused by the 
absence of other factors (for example inhibiting ones) would not be observed, 
because the cells should undergo apoptosis. To study these possibilities more 
precisely dialysis should be performed so that differentiation-inhibiting and  
-promoting factors are separated if they differ in size. Additionally, dialysis the other 
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way round could be performed (PBS in a dialysis tubing with a cut-off of 6kD 
dialyzed against serum already dialysed first with a cut-off with 3kD). Alternatively, 
also a combination between dialysis (cut-off 3kD) and centrifugation with Vivaspin 
tubes (cut-off 6kD) should be performed. If differentiation with the obtained fraction 
would be comparable to the positive control, this would support the finding of the first 
experiment. In a next step specific types of constituents within this fraction should be 
removed and tested again. One possibility would be the removal of lipophilic 
constituents with Freon, a chlorofluorocarbon (CFC) refrigerant. Other promising 
experiments would be the fractionation of serum with HPLC (high pressure liquid 
chromatography) and silver staining of the different fractions after gel 
electrophoresis. If these experiments resulted in further indications, mass 
spectrometry could be used for the final identification of the factor(s) of interest. 
 
 
5.2 SPTB, C7 and the lentiviral infection of human erythroblasts 
 
Western blot analysis supported the findings from the mRNA expression profiling: In 
human, T3 regulates the expression of SPTB and C7 during erythroid differentiation. 
Cells maturing in the presence of T3 showed faster and stronger increase of the 
major erythroid protein SPTB. In particular, it is responsible for the typical bi-concave 
shape of erythrocytes. As SPTB expression increased during differentiation it could 
be seen as a sign for the level of maturation of erythrocytes. Erythroid cells 
differentiated in the presence of T3 showed a more mature phenotype, especially in 
cytospins. Higher amounts of SPTB in these cells were therefore expected and 
observed.  
The expression of C7 during differentiation was more complex in comparison to 
SPTB. Whereas cells differentiated in the absence of T3 exhibited an increase in C7 
expression, C7 levels in T3-treated cells peaked after 96 hours followed by a rapid 
decrease. C7 could be essential for the condensation of the nucleus, a crucial action 
during differentiation and needed for the following process of enucleation. Caspases 
usually contribute to apoptosis, consequently C7 expression decreased at the end of 
differentiation. The T3-caused up- and late down-regulation of C7 could be the main 
reason for the presence of more enucleated erythroid cells in the corresponding 
erythroid cultures. 
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To elucidate the role of SPTB and C7 in erythroid differentiation more precisely, it 
would be interesting to know which effects are caused by a knock-down of these 
genes. Because of previous experiences in our group (transfection and retroviral 
infections of human erythroblasts failed) we looked for alternative methods. We 
decided to use lentiviral vectors to utilise the RNAi mechanism. After infection of 
human erythroblasts inefficient infection-rates were observed (best infection: approx. 
20%). Because of these inefficient rates we were not able to detect any knock down, 
much less a detectable effect. Because of restrictions in the biosafety guidelines of 
the Division of Gynecological Endocrinology of the General Hospital Vienna (see 
Appendix), as well as the sensitivity and restricted life time of human erythroblasts, 
we were not able to sort the cells. Some improvement in the infection rate could be 
obtained with alternative infection protocols like for example spin infection (Tripp, Liu 
et al. 2003) or different ratios of the 3 vectors used for lentivirus-production. The 
increase in infection rates reached by these improvements, however, is not sufficient 
to see effects on gene expression. In addition to a general higher infection rate also 
multiple infections of the erythroblasts are desirable. That would cause multiple 
integrations into the genome of the erythroblasts and therefore an increased amount 
of shRNA in the cell, which should result in a more efficient knock down of the gene 
of interest. To achieve this, the lentivirus supernatant has to be concentrated, for 
example 100fold. The concentration can be done by ultracentrifugation, as described 
in the literature. During this diploma thesis it was not possible to concentrate virus 
supernatants because of absent approbations in the biosaftey level II approvals of 
the Max F. Perutz Laboratories and our collaboration partners in the IMP and AKH 
Vienna. 
 
The consequential combination of the presented data creates a promising future 
perspective. The data suggest that until now unidentified factors for erythroid 
differentiation in human serum can be found in a well-defined small size-range. 
Furthermore, findings of the mRNA expression profiling were confirmed at the 
protein level. Future experiments are necessary to elucidate these unidentified 
differentiation factors and the specific role of SPTB and C7 in erythropoiesis. 
 
 
.
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6 List of Abbreviations 
 
 
ADAM A disintegrin & metalloprotease 
AGM Aorta-gonad mesoneprhros region 
AKH Allgemeines Krankenhaus Wien 
AML Acute myeloid leukaemia 
BFU Burst forming unit 
BFU-E BFU-erythroid 
BSA Bovine serum albumin 
C3 Caspase 3 
C7 Caspase 7 
Caspase Cysteinyl aspartate proteinase 
CD Cluster of differentiation 
CFC Chlorofluorocarbon 
CFU Colony forming unit 
CFU-E CFU-erythroid 
CLP Common lymphoid progenitor 
CMP Common myeloid progenito 
DEMEM Dulbecco’s modified Eagle’s medium 
Dex Dexamethasone 
DHT Dihydro-testosterone 
DMSO Dimethyl sulfoxide 
DNA Desoxyribonucleic acid 
EDTA Ethylenediaminotetraacetic acid 
eIF4E Eukaryotic translation initiation factor 4E 
EMEM Eagle’s minimal essential medium 
Emp Erythroblast macrophage protein 
Epo Erythropoietin 
EpoR Epo receptor 
Flt3 Fibromyalgia syndrome like tyrosine kinase 3 
FMS Fibromyalgia syndrome 
G-CSF Granulocyte-colony-stimulating factor 
GMP Granulocyte/macrophage progenitor 
GPA Glycophorin A 
G-protein Guanine nucleotide-binding protein 
HCK Haematopoietic cell kinase 
HSC Haematopoietic stem cell 
Igf 1 Insulin-like growth factor 
IL-6 Interleukin-6 
IMP Inosine monophosphat 
IMP Institute of Molecular Pathology  
kD kilo Dalton 
Lin Lineage 
LT-HSCs Long term-HSC 
MAP Mitogen-activated protein 
MEL Mouse erythroleukaemia 
MEP Megakaryocyte/erythroid progenitor 
MFPL Max F. Perutz Laboratories 
MMP Matrix metalloproteinase 
MPP Multipotent progenitor 
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NKC Matural killer cell 
OD Optical density 
o/n Over night 
PBS Phosphate buffered saline 
PFA Paraformaldehyde 
RBV Retronectin bound virus 
RNA Ribonuleic acid 
RNAi RNA interference 
SCF Stem cell factor 
SDF-1 Stromal-derived-factor-1 
shRNA Short hairpin RNA 
Sl Steel locus 
SPTB Spectrin beta 
STAT5 Signal transducer and activator of transcription 5 
ST-HSC Short term-HSC 
T3 3,5,3’-triiodothyronine 
TNF Tumour necrosis factor 
TRα Thyroid hormone receptor alpha 
TRß Thyroid hormone receptor beta 
U Units 
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8 Appendix 
 
 
8.1 Bio-saftey guidlines for working with lentiviral vectors 
 
 
 
Working with Lentiviral vectors - safety regulations 
 
 
Be sure that you read and signed the safety rules before starting your work with 
lentiviruses!!!  
 
 
A: Working with lentiviruses and cells 
 
1. work with lentiviral particles may only be done in the reserved laminar flow hood in room 5Q.9.06 
 
2. start/duration of work with viral particles must be noted on the biohazard sign on the hood, 
together with the name of the responsible person 
 
3. all relevant informations regarding virus production, target cell infection, nature of constructs must 
be noted in the log book immediately after completion of work. 
 
4. all cell culture vessels must be labelled with date, name and room number (e.g. 5Q.012)  
 
5. NO open vessels may be taken out of the hood 
 
6. NO aerosol-producing steps (vortexing, resuspension of cells by pipetting) may be done outside 
the laminar flow hood 
 
7. for transfer of culture vessels from the hood to the incubator or to the inverted microscope, leak-
proof boxes have to be used to avoid spillage 
 
8. all liquid waste has to be decontaminated with 10 % hypochloride solution and autoclaved 
 
9. all cell culture plasticware has to be decontaminated with 10% hypochloride and autoclaved 
 
10. full (liquid/solid) waste containers must be autoclaved immediately (use 2 waste bags for solid 
waste). 
 
11. all working materials (unused tubes, pipetboys, tip boxes) which are removed from the hood must 
be cleaned with a viricidal disinfectant 
 
12. after completion of work, the hood must be cleaned with a viricidal disinfectant 
 
 
 
 
 
B: Personal protective equipment 
 
13. lab coats and double gloves (the lower pair taped to the coat) are mandatory when working with 
virus 
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14. upper set of gloves must be removed and discarded when leaving the hood and discarded in the 
plastikwaste and autocleved. 
 
15. safety goggles should be worn  
 
16.  double pair of gloves, laboratory coats and security glasses have to be used by every researcher 
 
 
 
C: In case of spillage: 
 
17. be prepared for spillage!!!  
 
18. this means that paper towels and viricidal disinfectant must be available when working with virus  
 
19. inform other people and close off the area 
 
20. suck up spills with paper towels, apply disinfectant, leave for the recommended time, remove 
disinfectant, wipe dry 
 
 
 
D: Further guidelines: 
 
21. plan your experiments thoroughly  
 
22. inform person responsible for lentiviral working area before starting work with lentivirus 
 
23. check for the availability of hypochloride, viricidal disinfectant, waste bags etc. BEFORE starting 
your work  
 
24. work slowly and concentrated  
 
25. be prepared for spills 
 
26. transfer all materials needed to the hood before starting work 
 
 
 
E: Rules for flow cytometry: 
 
27. virally infected cells must be fixed before flow cytometry and the cytometer must be flushed 
thoroughly with bleach after analysis 
 
28. capped FACS tubes should be used  
 
29. cell sorting: sorting of virally infected cells has to be arranged with sorting facility according to 
their safety regulations; some institutions allow cell sorting 7 passages after infection. 
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